name: Urine Ammonium Oxalate Crystal Measurement


name: VEGFR/PDGFR Tyrosine Kinase Inhibitor TAK-593


name: Control of Drug Substance: Validation of Analytical Procedures


name: Final Package Insert (Package Inserts, Patient Information, Medication Guides)


name: Sodium Phosphate/Sodium Biphosphate Laxative


name: Focused Ion Beam-Scanning Electron Microscope


name: Fragmented Parathyroid Hormone Measurement


name: Gamma Glutamyl Transferase to Creatinine Ratio Measurement


name: West North Central States Census Division


name: West South Central States Census Division


name: Measurement of Left Ventricular Ejection Fraction


name: Family Counseling for Substance Abuse Treatment


name: NEONATAL DEATH, 1624C-T (allelic variant)


name: HEMOGLOBIN J (BUDA), LYS61ASN (allelic variant)


name: LI-FRAUMENI SYNDROME 1, ARG248GLN (allelic variant)


name: AMYLOID POLYNEUROPATHY-NEPHROPATHY, IOWA TYPE, GLY26ARG (allelic variant)


name: {7 (24 HR lamotrigine 100 MG Extended Release Oral Tablet [Lamictal]) / 14 (24 HR lamotrigine 25 MG Extended Release Oral Tablet [Lamictal]) / 14 (24 HR lamotrigine 50 MG Extended Release Oral Tablet [Lamictal]) } Pack [Lamictal XR Orange Patient Titration Kit (for Patients Not Taking Carbamazepine, Phenytoin, Phenobarbital, Primidone, or Valproate)]


name: {7 (24 HR lamotrigine 100 MG Extended Release Oral Tablet) / 14 (24 HR lamotrigine 25 MG Extended Release Oral Tablet) / 14 (24 HR lamotrigine 50 MG Extended Release Oral Tablet) } Pack


name: {21 (24 HR lamotrigine 25 MG Extended Release Oral Tablet) / 7 (24 HR lamotrigine 50 MG Extended Release Oral Tablet) } Pack


name: {21 (24 HR lamotrigine 25 MG Extended Release Oral Tablet [Lamictal]) / 7 (24 HR lamotrigine 50 MG Extended Release Oral Tablet [Lamictal]) } Pack [Lamictal XR Blue Patient Titration Kit (for Patients Taking Valproate)]


name: Monoject Prefill Advanced, 100 units/mL intravenous solution


name: PredniSONE Anhydrous, compounding powder


name: {14 (24 HR lamotrigine 100 MG Extended Release Oral Tablet) / 7 (24 HR lamotrigine 200 MG Extended Release Oral Tablet) / 14 (24 HR lamotrigine 50 MG Extended Release Oral Tablet) } Pack


name: {14 (24 HR lamotrigine 100 MG Extended Release Oral Tablet [Lamictal]) / 7 (24 HR lamotrigine 200 MG Extended Release Oral Tablet [Lamictal]) / 14 (24 HR lamotrigine 50 MG Extended Release Oral Tablet [Lamictal]) } Pack [Lamictal XR Green Patient Titration Kit (for Patients Taking Carbamazepine, Phenytoin, Phenobarbital, or Primidone, and Not Taking Valproate)]


name: Paradigm Quick-set Infusion Set 6MM-18 inch


name: Heparin Sodium 100 U/1 ML Intravenous Solution [POSIFLUSH HEPARIN]


name: {60 (caffeine 65 MG / riboflavin 6.25 MG / thiamine 25 MG / vitamin B12 0.125 MG / vitamin B6 25 MG Oral Capsule) / 60 (ibuprofen 400 MG Oral Tablet) } Pack [IC 400 Kit]


name: {60 (Caffeine 65 MG / Riboflavin 6.25 MG / Thiamine 25 MG / Vitamin B 12 0.125 MG / Vitamin B6 25 MG Oral Capsule) / 60 (Ibuprofen 800 MG Oral Tablet) } Pack [IC 800 Kit]


name: {21 (lamotrigine 25 MG Disintegrating Oral Tablet) / 7 (lamotrigine 50 MG Disintegrating Oral Tablet) } Pack


name: {21 (lamotrigine 25 MG Disintegrating Oral Tablet [Lamictal]) / 7 (lamotrigine 50 MG Disintegrating Oral Tablet [Lamictal]) } Pack [Lamictal ODT Blue Patient Titration Kit (for Patients Taking Valproate)]


name: {7 (lamotrigine 100 MG Disintegrating Oral Tablet) / 14 (lamotrigine 25 MG Disintegrating Oral Tablet) / 14 (lamotrigine 50 MG Disintegrating Oral Tablet) } Pack


name: {7 (lamotrigine 100 MG Disintegrating Oral Tablet [Lamictal]) / 14 (lamotrigine 25 MG Disintegrating Oral Tablet [Lamictal]) / 14 (lamotrigine 50 MG Disintegrating Oral Tablet [Lamictal]) } Pack [Lamictal ODT Orange Patient Titration Kit (For Patients Not Taking Enzyme-Inducing Drugs or Valproate)]


name: {14 (lamotrigine 100 MG Disintegrating Oral Tablet) / 42 (lamotrigine 50 MG Disintegrating Oral Tablet) } Pack


name: {14 (lamotrigine 100 MG Disintegrating Oral Tablet [Lamictal]) / 42 (lamotrigine 50 MG Disintegrating Oral Tablet [Lamictal]) } Pack [Lamictal ODT Green Titration Kit (for Patients Taking Enzyme-Inducing Drugs and Not Taking Valproate)]


name: polymyxin B sulfate,micronized 100 million unit (not less than 6,000 unit/mg,USP) MISCELL POWDER (EA)


name: amlodipine / hydrochlorothiazide / valsartan


name: Avobenzone/Octinoxate/Octisalate 3%-7.5%-2% Topical application Lotion


name: DEPEND BELTED SHIELDS W/BUTTONS,EXTRA ABSORB


name: DEPEND BELTED SHIELDS W/TABS,EXTRA ABSORB


name: DEPEND FITTED BRIEF,MAXIMUM ABSORB LARGE


name: DEPEND FITTED BRIEF,MAXIMUM ABSORB SMALL/MEDIUM


name: compound vehicle solution sugar-free no.1 ORAL SOLUTION, ORAL


name: CeraLyte 50, oral powder for reconstitution


name: CeraLyte 70, oral powder for reconstitution


name: emollient combination no.43 TOPICAL CREAM (GRAM)


name: hydroxyamphetamine hydrobromide 100 % MISCELL POWDER (GRAM)


name: {21 (ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet) / 7 (ferrous fumarate 75 MG Oral Tablet) } Pack [Gildess FE 1.5/30 28 Day]


name: {21 (ethinyl estradiol 0.02 MG / levonorgestrel 0.1 MG Oral Tablet) / 7 (ferrous fumarate 75 MG Oral Tablet) } Pack


name: compounding vehicle solution sugar free no. 1


name: nut.therapy, phenylketonuria(PKU) with iron, no.39


name: TRACH TUBE,SZ 5 INNER CANNULA SHLY #50XLTIN


name: {21 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) / 7 (ferrous fumarate 75 MG Oral Tablet) } Pack [Gildess FE 1/20 28 Day]


name: emergency intervention: evacuation by airplane - priority


name: emergency intervention: evacuation by airplane - routine


name: emergency intervention: evacuation by airplane - urgent


name: endotracheal tube assessment cuff pressure


name: staging phase of transport to military medical facility


name: stool culture vancomycin-resistant Enterococcus


name: nonspecific circulating anticoagulants panel


name: surgical pathology special stains phosphofructokinase histochemical stain


name: surrogate mother implanted with egg from unrelated donor


name: surrogate mother impregnated with sperm from unrelated donor


name: sweat drug screen by multiple class procedure


name: sweat drug screen by single class procedure


name: oral fluid drug screen by multiple class procedure


name: oral fluid drug screen by single class procedure


name: transfer to another medical facility with basic life support cardiac


name: transfer to military medical facility phase of transport


name: ground phase of transport to military medical facility


name: flight phase of transport to military medical facility


name: cabin altitude phase of transport to military medical facility


name: transfer to military medical facility pre-flight assessment


name: transfer to military medical facility post-flight assessment


name: pancreatic surgery enteric conversion of bladder drainage


name: pancreatic transplantation of allograft with bladder drainage


name: pancreatic transplantation of allograft with enteric drainage


name: transfer to another medical facility with advanced life support cardiac


name: transfer to another medical facility with advanced life support trauma


name: transfer to another medical facility with advanced life support pediatric


name: insertion of vertical expandable prosthetic titanium rib


name: lengthening of vertical expandable prosthetic titanium rib


name: reproductive services for surrogate mother


name: catheter ablation for atrial fibrillation


name: catheter ablation for supraventricular tachycardia


name: catheter ablation for atrial tachycardia


name: x-ray of lumbosacral spine: facet joint fluid


name: serum Herpes simplex IgM antibody test by indirect fluorescent antibody


name: comprehensive metabolic panel with hepatic panel


name: serum enterohemorrhagic Escherichia coli O157:H7 detection by enzyme immunoassay


name: free kappa and lambda light chain assays


name: urine toxicology screen by gas chromatography or mass spectrometry


name: serum antiplatelet antibody test by indirect assay


name: chromosome analysis by lymphocyte culture


name: serum transferrin, iron, and total iron binding capacity tests


name: computed tomography of lumbar spine: ligaments


name: urine drug screen single class procedure


name: urine drug screen multiple class procedure


name: saliva drug screen by single class procedure


name: saliva drug screen by multiple class procedure


name: gastric contents drug screen by single class procedure


name: gastric contents drug screen by multiple class procedure


name: hair drug screen by single class procedure


name: hair drug screen by multiple class procedure


name: x-rays of knee with lateral and Merchant views


name: KRN7000-Pulsed Autologous Dendritic Cells


name: Anti-Integrin Monoclonal Antibody-DM4 Immunoconjugate IMGN388


name: Known allergies or adverse drug reactions:Find:Pt:^Patient:Ord:CARE


name: Brief interview for mental status was attempted:Find:Pt:^Patient:Ord:CARE


name: Reason brief interview for mental status was not attempted:Find:Pt:^Patient:Ord:CARE


name: Memory &or recall ability during 2D assessment period:Find:2D:^Patient:Nom:CARE


name: Drug efficacy sequence variation interpretation


name: Continuity assessment record and evaluation tool - master document - core and supplemental items:-:Pt:^Patient:-


name: Support Needs &or Caregiver Assistance:-:Pt:^Patient:-


name: Patient History Prior to this Current Illness, Exacerbation, or Injury:-:Pt:^Patient:-


name: Patient lived with prior to this illness:Find:Pt:^Patient:Nom:CARE


name: Autoantibodies:Imp:Pt:Ser:Nar:IF rat liver+stomach+kidney substrate


name: Nuclear mitotic apparatus Ab:PrThr:Pt:Ser:Ord:IF


name: Nuclear mitotic apparatus Ab:Titr:Pt:Ser:SemiQn:IF


name: Nuclear Ab pattern.intercellular bridge:PrThr:Pt:Ser:Ord:IF


name: Repetition of three words:Num:Pt:^Patient:Ord:BIMS


name: Temporal orientation - current year:Find:Pt:^Patient:Ord:BIMS


name: Temporal orientation - current month:Find:Pt:^Patient:Ord:BIMS


name: Deprecated Temporal orientation - current day of the week [Observed.BIMS]


name: Patient Identification Number or Provider Account Number:ID:Pt:^Patient:Nom


name: Major treatments admitted &or discharged with panel:-:Pt:^Patient:-


name: Allergies & Adverse Drug Reactions:-:Pt:^Patient:-


name: Allergy or cause of reaction:Find:Pt:^Patient:Nom


name: Temporal Orientation &or Mental Status:-:Pt:^Patient:-


name: Temporal orientation - CARE:-:Pt:^Patient:-


name: Observational Assessment of Cognitive Status at 2D Assessment Period:-:2D:^Patient:-


name: Behavioral Signs & Symptoms:-:Pt:^Patient:-


name: Patient health questionnaire 2 item:-:Pt:^Patient:-:Reported.PHQ-2.CARE


name: Pain Effect on Function during last 2D:-:2D:^Patient:-


name: Structural barriers in prior residence that could interfere with the patient's discharge:Find:Pt:^Patient:Nom


name: Prior functioning.mobility - ambulation:Find:Pt:^Patient:Ord:CARE


name: Prior functioning.stairs - ambulation:Find:Pt:^Patient:Ord:CARE


name: Prior functioning.mobility - wheelchair:Find:Pt:^Patient:Ord:CARE


name: Mobility devices and aids used prior to current illness, exacerbation, or injury:Find:Pt:^Patient:Nom:CARE


name: Prior mobility device.other specified:Find:Pt:^Patient:Nom:CARE


name: Major treatments admitted &or discharged with:Find:Pt:^Patient:Nom:CARE


name: Unable to assess memory &or recall ability during 2D assessment period .specified reason:Find:2D:^Patient:Nom:CARE


name: Physical behavioral symptoms directed toward others during 2D assessment period:Find:2D:^Patient:Ord:CARE


name: Verbal behavioral symptoms directed towards others during 2D assessment period:Find:2D:^Patient:Ord:CARE


name: Other disruptive or dangerous behavioral symptoms not directed towards others, including self-injurious behaviors during 2D assessment period:Find:2D:^Patient:Ord:CARE


name: Mood interview was attempted:Find:Pt:^Patient:Ord:CARE


name: Any impairments with swallowing:Find:Pt:^Patient:Ord:CARE


name: Frequency of assistance at discharge:Find:Pt:^Patient:Ord:CARE


name: Discharge destination influenced by caregiver availability:Find:Pt:^Patient:Ord:CARE


name: Patient will live with at discharge:Find:Pt:^Patient:Nom:CARE


name: Medication administration assistance needed:Find:Pt:^Patient:Nom:CARE


name: Medical procedures &or treatments assistance needed:Find:Pt:^Patient:Nom:CARE


name: Management of equipment assistance needed:Find:Pt:^Patient:Nom:CARE


name: Supervision and safety assistance needed:Find:Pt:^Patient:Nom:CARE


name: Home health care considered appropriate:Find:Pt:^Patient:Nom:CARE


name: Skilled nursing facility considered appropriate:Find:Pt:^Patient:Nom:CARE


name: Inpatient rehabilitation hospital considered appropriate:Find:Pt:^Patient:Nom:CARE


name: Long term care hospital considered appropriate:Find:Pt:^Patient:Nom:CARE


name: Psychiatric hospital considered appropriate:Find:Pt:^Patient:Nom:CARE


name: Outpatient services considered appropriate:Find:Pt:^Patient:Nom:CARE


name: Acute hospital admission considered appropriate:Find:Pt:^Patient:Nom:CARE


name: Long-term personal care services considered appropriate:Find:Pt:^Patient:Nom:CARE


name: Long term care nursing facility considered appropriate:Find:Pt:^Patient:Nom:CARE


name: Other service considered appropriate:Find:Pt:^Patient:Nom:CARE


name: Discharged with referral for additional services:Find:Pt:^Patient:Ord:CARE


name: Discharge delayed at least 24H:Find:Pt:^Patient:Ord


name: Reason for discharge delay:Find:Pt:^Patient:Nom


name: Reason for discharge delay.other specified:Find:Pt:^Patient:Nom:CARE


name: Patient requested information not be shared with next provider:Find:Pt:^Patient:Ord:CARE


name: Primary diagnosis code from previous setting:Prid:Pt:^Patient:Nom:CARE


name: Quality Health Reporting Document Architecture set


name: Quality Health Reporting Document Architecture survey


name: Medical services received in the last 2Mo:Find:2Mo:^Patient:Nom:CARE


name: Continuity assessment record and evaluation tool - Acute care:-:Pt:^Patient:-:CARE


name: Continuity assessment record and evaluation tool - Acute care


name: Continuity assessment record and evaluation tool - Post acute care - admission:-:Pt:^Patient:-:CARE


name: Continuity assessment record and evaluation tool - Post acute care - discharge:-:Pt:^Patient:-:CARE


name: Continuity assessment record and evaluation tool - Home health admission:-:Pt:^Patient:-:CARE


name: Continuity assessment record and evaluation tool - Home health admission


name: Major treatments admitted with panel:-:Pt:^Patient:-


name: Major treatments admitted with:Find:Pt:^Patient:Nom:CARE


name: Major treatments discharged with panel:-:Pt:^Patient:-


name: Major treatments discharged with:Find:Pt:^Patient:Nom:CARE


name: Fatty acids.very long chain.C22:1n9:MCnc:Pt:Ser/Plas:Qn


name: Fatty acids.very long chain.C26:1:MCnc:Pt:Ser/Plas:Qn


name: FLT3 gene targeted mutation analysis:Find:Pt:Bone mar:Doc:Molgen


name: NPM1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: SMN2 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: CYP2C9 & VKORC1 panel:-:Pt:Bld/Tiss:-:Molgen


name: Drug metabolism sequence variation interpretation


name: Mouth or facial pain, discomfort or difficulty with chewing in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Dental status - none of the above in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Pressure injury risk by resident has a stage 1 or greater, a scar over bony prominence, or a non-removable dressing, device in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Pressure injury risk by formal assessment:Find:Pt:^Patient:Ord:MDSv3


name: Glasgow coma score special circumstances:Type:Pt:^Patient:Nom


name: Physical examination by body areas:-:Pt:^Patient:Set


name: Calcium.ionized^^adjusted to pH 7.4:SCnc:Pt:BldCo:Qn


name: Cystatin C to Creatinine Ratio Measurement


name: R wave duration.lead AVR:Time:Pt:Heart:Qn:EKG


name: Bacterial vaginosis & vaginitis DNA panel:-:Pt:Vag:-:Probe.amp.sig


name: Nuclear Ab pattern.intercellular bridge:Titr:Pt:Ser:SemiQn:IF


name: RNA polymerase I Ab:Titr:Pt:Ser:SemiQn:IF


name: Cytomegalovirus DNA:NCnc:Pt:Urine:Qn:Probe.amp.tar detection limit = 200 copies/mL


name: Tumor necrosis factor binding protein:ACnc:Pt:Ser:Qn


name: Legionella pneumophila 7+8+9+10+11+12+13+14 Ab:Titr:Pt:Ser:SemiQn


name: Coagulation surface induced.factor substitution^immediately after addition of factor V depleted plasma:Time:Pt:PPP:Qn:Coag


name: Coagulation surface induced.factor substitution^immediately after addition of factor V depleted plasma+APC:Time:Pt:PPP:Qn:Coag


name: Hepatitis B virus basal core promoter mutation:Prid:Pt:Ser:Nom:Probe.amp.tar


name: Cortisol^24H post dose dexamethasone:SCnc:Pt:Ser/Plas:Qn


name: Cortisol^3D post dose dexamethasone:SCnc:Pt:Ser/Plas:Qn


name: Cortisol^4D post dose corticotropin:SCnc:Pt:Ser/Plas:Qn


name: Cortisol^5D post dose dexamethasone:SCnc:Pt:Ser/Plas:Qn


name: Cortisol^5H post dose corticotropin:SCnc:Pt:Ser/Plas:Qn


name: Insulin-like growth factor binding protein 1^pre or post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Public health notifiable condition:Prid:Pt:XXX:Nom


name: Coagulation thrombin induced.factor substitution^immediately after 1:4 addition of normal plasma:Time:Pt:PPP:Qn:Coag


name: Lymphoma - acute screen markers:Imp:Pt:XXX:Nar


name: Lymphoma - CLL screen markers:Imp:Pt:XXX:Nar


name: Lymphoma - T-cell markers:Imp:Pt:XXX:Nar


name: Immune response panel:-:Pt:XXX:-:Flow cytometry


name: Lymphoma - acute screen panel:-:Pt:XXX:-:Flow cytometry


name: Lymphoma - CLL screen panel:-:Pt:XXX:-:Flow cytometry


name: Lymphoma - T-cell screen panel:-:Pt:XXX:-:Flow cytometry


name: Cell count & Differential panel with Glucose & Protein:-:Pt:CSF:Qn


name: Semen analysis fertility panel:-:Pt:Semen:-


name: Cell count & Differential panel with Glucose & Protein:-:Pt:Body fld:-


name: Cortisol^9 AM 2nd day specimen:MCnc:Pt:Ser/Plas:Qn


name: Corticotropin^9 AM 2nd day specimen:MCnc:Pt:Plas:Qn


name: Influenza virus B Ag:PrThr:Pt:Isolate:Ord


name: Protein & Glucose panel:MCnc:Pt:Body fld:Qn


name: Glucose^10M pre dose glucagon:SCnc:Pt:Ser/Plas:Qn


name: Glucose^15M post dose glucagon:SCnc:Pt:Ser/Plas:Qn


name: Glucose^15M pre dose glucagon:SCnc:Pt:Ser/Plas:Qn


name: Glucose^20M post dose glucagon:SCnc:Pt:Ser/Plas:Qn


name: Glucose^2M post dose glucagon:SCnc:Pt:Ser/Plas:Qn


name: Glucose^4M post dose glucagon:SCnc:Pt:Ser/Plas:Qn


name: Glucose^5M pre dose glucagon:SCnc:Pt:Ser/Plas:Qn


name: Glucose^6M post dose glucagon:SCnc:Pt:Ser/Plas:Qn


name: Glucose^8M post dose glucagon:SCnc:Pt:Ser/Plas:Qn


name: Glucose^pre dose insulin IV:SCnc:Pt:Ser/Plas:Qn


name: Glucose^2H post dose insulin IV:SCnc:Pt:Ser/Plas:Qn


name: Glucose^2.5H post dose insulin IV:SCnc:Pt:Ser/Plas:Qn


name: Glucose^15M post dose insulin IV:SCnc:Pt:Ser/Plas:Qn


name: Glucose^15M pre dose insulin IV:SCnc:Pt:Ser/Plas:Qn


name: Glucose^3H pre dose insulin IV:SCnc:Pt:Ser/Plas:Qn


name: Glucose^30M post dose insulin IV:SCnc:Pt:Ser/Plas:Qn


name: Glucose^45M post dose insulin IV:SCnc:Pt:Ser/Plas:Qn


name: Glucose^1H post dose insulin IV:SCnc:Pt:Ser/Plas:Qn


name: Glucose^1.3H post dose insulin IV:SCnc:Pt:Ser/Plas:Qn


name: Glucose^1.5H post dose insulin IV:SCnc:Pt:Ser/Plas:Qn


name: Glucose^pre dose ornithine alpha-ketoglutarate:SCnc:Pt:Ser/Plas:Qn


name: Glucose^2H post dose ornithine alpha-ketoglutarate:SCnc:Pt:Ser/Plas:Qn


name: Glucose^2.5H post dose ornithine alpha-ketoglutarate:SCnc:Pt:Ser/Plas:Qn


name: Glucose^15M post dose ornithine alpha-ketoglutarate:SCnc:Pt:Ser/Plas:Qn


name: Glucose^15M pre dose ornithine alpha-ketoglutarate:SCnc:Pt:Ser/Plas:Qn


name: Glucose^3H post dose ornithine alpha-ketoglutarate:SCnc:Pt:Ser/Plas:Qn


name: Glucose^30M post dose ornithine alpha-ketoglutarate:SCnc:Pt:Ser/Plas:Qn


name: Glucose^45M post dose ornithine alpha-ketoglutarate:SCnc:Pt:Ser/Plas:Qn


name: Glucose^1H post dose ornithine alpha-ketoglutarate:SCnc:Pt:Ser/Plas:Qn


name: Glucose^1.5H post dose ornithine alpha-ketoglutarate:SCnc:Pt:Ser/Plas:Qn


name: Fatty acids.very long chain.C26:0/Creatinine:SRto:Pt:Urine:Qn


name: Fatty acids.very long chain.C26:0/Creatinine


name: Glucose^5th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Glucose^6th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Glucose^7th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Glucose^8th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Assessment &or tracking type:-:Pt:^Patient:-


name: Social Security & Medicare numbers:-:Pt:^Patient:-


name: Hearing, speech, and vision:-:Pt:^Patient:-:CMS Assessment


name: Feeling or appearing down, depressed or hopeless in last 2W.presence:Find:2W:^Patient:Ord:Observed.PHQ-9.CMS


name: Feeling or appearing down, depressed, or hopeless in last 2W.frequency:Find:2W:^Patient:Ord:Observed.PHQ-9.CMS


name: Trouble falling or staying asleep, or sleeping too much in last 2W.presence:Find:2W:^Patient:Ord:Observed.PHQ-9.CMS


name: Trouble falling or staying asleep, or sleeping too much in last 2W.frequency:Find:2W:^Patient:Ord:Observed.PHQ-9.CMS


name: Feeling tired or having little energy in last 2W.presence:Find:2W:^Patient:Ord:Observed.PHQ-9.CMS


name: Feeling tired or having little energy in last 2W.frequency:Find:2W:^Patient:Ord:Observed.PHQ-9.CMS


name: Poor appetite or overeating in last 2W.presence:Find:2W:^Patient:Ord:Observed.PHQ-9.CMS


name: Poor appetite or overeating in last 2W.frequency:Find:2W:^Patient:Ord:Observed.PHQ-9.CMS


name: Number of pressure injuries - stage 1:Num:Pt:^Patient:Qn:CMS Assessment


name: Deprecated One or more unhealed pressure ulcer(s) at Stage 2 or higher, or one or more likely pressure ulcers that are unstageable MDSv3


name: Number of pressure injuries present upon admission &or reentry - stage 2:Num:Pt:^Patient:Qn:CMS Assessment


name: Number of pressure injuries present upon admission &or reentry - stage 3:Num:Pt:^Patient:Qn:CMS Assessment


name: Date of onset of pressure injuries onset in this facility - oldest or only stage 3:Date:Pt:^Patient:Qn:MDSv3


name: Number of pressure injuries present upon admission &or reentry - stage 4:Num:Pt:^Patient:Qn:CMS Assessment


name: Date of onset of pressure injuries onset in this facility - oldest or only stage 4:Date:Pt:^Patient:Qn:MDSv3


name: Number of pressure injuries - unstageable due to non-removable dressing or device:Num:Pt:^Patient:Qn:CMS Assessment


name: Number of pressure injuries present upon admission &or reentry - unstageable due to non-removable dressing:Num:Pt:^Patient:Qn:CMS Assessment


name: Staff assessment for mental status:-:Pt:^Patient:-:MDSv3


name: Proportion of total calories the resident received through parenteral or tube feedings in the last 7D:EngFr:7D:^Patient:Qn:MDSv3


name: Neuronal nuclear type 2 Ab:ACnc:Pt:CSF:Qn:IA


name: ED procedures and results:-:Pt:^Patient:Set:DEEDS


name: ED disposition and diagnosis data:-:Pt:^Patient:Set:DEEDS


name: Facility and Practitioner identification data:-:Pt:^Patient:Set:DEEDS


name: Facility and Practitioner identification data


name: ED arrival and first assessment data:-:Enctr^frst:^Patient:Set:DEEDS


name: ED History and Physical Examination Data:-:Pt:^Patient:Set:DEEDS


name: ED History and Physical Examination Data


name: Human epididymis protein 4:SCnc:Pt:Ser/Plas:Qn


name: Quality Reporting Document Architecture panel:-:Pt:XXX:-


name: Quality Reporting Document Architecture panel


name: Quality Reporting Document Architecture incidence report:Find:Pt:^Patient:Doc


name: Quality Reporting Document Architecture incidence report


name: Temporal orientation (orientation to year, month, and day):-:Pt:^Patient:-:BIMS


name: Temporal orientation (orientation to year, month, and day)


name: Behavioral symptom - presence & frequency:-:RptPeriod:^Patient:-:CMS Assessment


name: Impact on resident:-:RptPeriod:^Patient:-:CMS Assessment


name: Impact on others:-:RptPeriod:^Patient:-:CMS Assessment


name: Wandering - impact:-:7D:^Patient:-:CMS Assessment


name: Preferences for customary routine and activities:-:Pt:^Patient:-


name: Interview for daily preferences:-:Pt:^Patient:-:CMS Assessment


name: Interview for activity preferences:-:Pt:^Patient:-:CMS Assessment


name: Staff assessment of daily and activity preferences:-:Pt:^Patient:-


name: Staff assessment of daily and activity preferences


name: Activities of Daily Living (ADL) assistance in last 7D:-:7D:^Patient:-:CMS Assessment


name: Balance during transitions and walking:-:RptPeriod:^Patient:-:CMS Assessment


name: Functional limitation in range of motion:-:Pt:^Patient:-:CMS Assessment


name: Interview for daily and activity preferences should be conducted:Find:Pt:^Patient:Ord:CMS Assessment


name: How important it is to choose what clothes to wear while in this facility:Find:Pt:^Patient:Ord:CMS Assessment


name: How important it is to choose what clothes to wear while in this facility


name: How important it is to take care of your personal belongings or things while in this facility:Find:Pt:^Patient:Ord:CMS Assessment


name: How important it is to take care of your personal belongings or things while in this facility


name: How important it is to choose between a tub bath, shower, bed bath, or sponge bath while in this facility:Find:Pt:^Patient:Ord:CMS Assessment


name: How important it is to choose between a tub bath, shower, bed bath, or sponge bath while in this facility


name: How important it is to have snacks available between meals while in this facility:Find:Pt:^Patient:Ord:CMS Assessment


name: How important it is to have snacks available between meals while in this facility


name: How important it is to choose your own bedtime while in this facility:Find:Pt:^Patient:Ord:CMS Assessment


name: How important it is to choose your own bedtime while in this facility


name: How important it is to have your family or a close friend involved in discussions about your care while in this facility:Find:Pt:^Patient:Ord:CMS Assessment


name: How important it is to have your family or a close friend involved in discussions about your care while in this facility


name: How important it is to be able to use the phone in private while in this facility:Find:Pt:^Patient:Ord:CMS Assessment


name: How important it is to be able to use the phone in private while in this facility


name: How important it is to have a place to lock your things to keep them safe while in this facility:Find:Pt:^Patient:Ord:CMS Assessment


name: How important it is to have a place to lock your things to keep them safe while in this facility


name: How important it is to have books, newspapers, and magazines to read while in this facility:Find:Pt:^Patient:Ord:CMS Assessment


name: How important it is to have books, newspapers, and magazines to read while in this facility


name: How important it is to listen to music you like while in this facility:Find:Pt:^Patient:Ord:CMS Assessment


name: How important it is to listen to music you like while in this facility


name: How important it is to be around animals such as pets while in this facility:Find:Pt:^Patient:Ord:CMS Assessment


name: How important it is to be around animals such as pets while in this facility


name: How important it is to keep up with the news while in this facility:Find:Pt:^Patient:Ord:CMS Assessment


name: How important it is to keep up with the news while in this facility


name: How important it is to do things with groups of people while in this facility:Find:Pt:^Patient:Ord:CMS Assessment


name: How important it is to do things with groups of people while in this facility


name: How important it is to do your favorite activities while in this facility:Find:Pt:^Patient:Ord:CMS Assessment


name: How important it is to do your favorite activities while in this facility


name: How important it is to go outside to get fresh air when the weather is good while in this facility:Find:Pt:^Patient:Ord:CMS Assessment


name: How important it is to go outside to get fresh air when the weather is good while in this facility


name: Beta 2 globulin+Gamma globulin/Protein.total:MFr:Pt:Urine:Qn:Electrophoresis


name: Cytochrome C oxidase:CCnt:Pt:Amnio fld cells:Qn


name: Cytochrome C oxidase:CCnt:Pt:Amnio fld:Qn


name: Fibroblast growth factor 23.intact:MCnc:Pt:Ser/Plas:Qn


name: Glucose^1st specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Glucose^10th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Glucose^11th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Glucose^12th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Glucose^2nd specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Glucose^3rd specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Glucose^4th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Glucose^9th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Glucose^10M post dose glucagon:SCnc:Pt:Ser/Plas:Qn


name: Transfuse 5% plasma protein fraction units:Num:Pt:^BPU:Qn


name: Pooled platelet concentrate units given:Num:Pt:^BPU:Qn


name: Transfuse pooled cryoprecipitate units:Num:Pt:^BPU:Qn


name: Pooled cryoprecipitate units given:Num:Pt:^BPU:Qn


name: Transfuse pooled fresh frozen plasma units:Num:Pt:^BPU:Qn


name: Pooled fresh frozen plasma units given:Num:Pt:^BPU:Qn


name: Direct antiglobulin test.complement C3+C4 specific reagent:PrThr:Pt:RBC:Ord


name: Direct antiglobulin test.complement C3 specific reagent:PrThr:Pt:RBC:Ord


name: Rh immune globulin given:Find:Pt:^Patient:Ord


name: Cryoprecipitate poor plasma units given:Num:Pt:^BPU:Qn


name: Transfuse leukocyte-poor plateletpheresis units:Num:Pt:^BPU:Qn


name: Leukocyte-poor plateletpheresis units given:Num:Pt:^BPU:Qn


name: Transfuse leukocyte-poor platelets units:Num:Pt:^BPU:Qn


name: Transfuse fresh frozen plasma pediatric units:Num:Pt:^BPU:Qn


name: Transfuse fresh frozen plasma pediatric units


name: Whole blood pediatric units given:Num:Pt:^BPU:Qn


name: Frozen erythrocytes newborn units given:Num:Pt:^BPU:Qn


name: Transfuse frozen erythrocytes pediatric units:Num:Pt:^BPU:Qn


name: Transfuse frozen erythrocytes pediatric units


name: Frozen erythrocytes pediatric units given:Num:Pt:^BPU:Qn


name: Transfuse plateletpheresis half units:Num:Pt:^BPU:Qn


name: Plateletpheresis half units given:Num:Pt:^BPU:Qn


name: Fresh frozen plasma pediatric units given:Num:Pt:^BPU:Qn


name: Transfuse frozen erythrocytes newborn units:Vol:Pt:^Patient:Qn


name: Frozen packed erythrocytes given:Vol:Pt:^Patient:Qn


name: 5% plasma protein fraction given:Vol:Pt:^Patient:Qn


name: Pooled fresh frozen plasma given:Vol:Pt:^Patient:Qn


name: User safety warnings section:-:-:^FDA package insert:Nar


name: Blastomyces dermatitidis Ag:ACnc:Pt:Body fld:Qn


name: Granulocyte colony stimulating factor:MCnc:Pt:Ser/Plas:Qn


name: Alpha 1 globulin/Protein.total:MFr:Pt:Dial fld:Qn:Electrophoresis


name: Alpha 2 globulin/Protein.total:MFr:Pt:Dial fld:Qn:Electrophoresis


name: Cholesterol.in HDL 2a/Cholesterol.in HDL.total:MFr:Pt:Ser/Plas:Qn:Electrophoresis


name: Cholesterol.in HDL 2a/Cholesterol.in HDL.total


name: Cholesterol.in HDL 2b/Cholesterol.in HDL.total:MFr:Pt:Ser/Plas:Qn:Electrophoresis


name: Cholesterol.in HDL 2b/Cholesterol.in HDL.total


name: Cholesterol.in HDL 3a/Cholesterol.in HDL.total:MFr:Pt:Ser/Plas:Qn:Electrophoresis


name: Cholesterol.in HDL 3a/Cholesterol.in HDL.total


name: Cholesterol.in HDL 3b/Cholesterol.in HDL.total:MFr:Pt:Ser/Plas:Qn:Electrophoresis


name: Cholesterol.in HDL 3b/Cholesterol.in HDL.total


name: Cholesterol.in HDL 3c/Cholesterol.in HDL.total:MFr:Pt:Ser/Plas:Qn:Electrophoresis


name: Cholesterol.in HDL 3c/Cholesterol.in HDL.total


name: Octadecanedioylcarnitine (C18-DC) (DBS) [Moles/Vol]


name: Functional rehabilitation potential:-:Pt:^Patient:-:CMS Assessment


name: Urinary toileting program:-:Pt:^Patient:-:CMS Assessment


name: Psychiatric &or mood disorder:-:Pt:^Patient:-


name: None of above active diagnoses:-:Pt:^Patient:-


name: Additional ICD diagnosis 1 in last 7D:Prid:7D:^Patient:Nom


name: Additional ICD diagnosis 2 in last 7D:Prid:7D:^Patient:Nom


name: Additional ICD diagnosis 3 in last 7D:Prid:7D:^Patient:Nom


name: Additional ICD diagnosis 4 in last 7D:Prid:7D:^Patient:Nom


name: Additional ICD diagnosis 5 in last 7D:Prid:7D:^Patient:Nom


name: Additional ICD diagnosis 6 in last 7D:Prid:7D:^Patient:Nom


name: Additional ICD diagnosis 7 in last 7D:Prid:7D:^Patient:Nom


name: Additional ICD diagnosis 8 in last 7D:Prid:7D:^Patient:Nom


name: Additional ICD diagnosis 9 in last 7D:Prid:7D:^Patient:Nom


name: Additional ICD diagnosis 10 in last 7D:Prid:7D:^Patient:Nom


name: MDS v3.0 - RAI v1.17.1, 1.17.2 - Pain assessment interview during assessment period:-:RptPeriod:^Patient:-:CMS Assessment


name: Pain effect on function:-:RptPeriod:^Patient:-:CMS Assessment


name: Staff assessment for pain:-:Pt:^Patient:-


name: Indicators of pain or possible pain:-:Pt:^Patient:-


name: Swallowing &or nutritional status:-:Pt:^Patient:-


name: Nutritional approaches panel:-:Pt:^Patient:-:CMS Assessment


name: Percent intake by artificial route:-:Pt:^Patient:-


name: Determination of pressure injury risk:-:Pt:^Patient:-


name: Presence of pressure injury:-:Pt:^Patient:-


name: Current number of unhealed (non-epithelialized) pressure injuries at each stage:-:Pt:^Patient:-


name: Pressure injuries - stage 2:-:Pt:^Patient:-


name: Pressure injuries - stage 3:-:Pt:^Patient:-


name: Pressure injuries - stage 4:-:Pt:^Patient:-


name: Pressure injuries - unstageable due to non-removable dressing:-:Pt:^Patient:-


name: PPS Other Medicare Required Assessment - OMRA:Find:Pt:^Patient:Nom:CMS Assessment


name: PPS Other Medicare Required Assessment - OMRA


name: First assessment since the most recent admission &or reentry:Find:Pt:^Patient:Ord:CMS Assessment


name: Preadmission Screening and Resident Review (PASRR):Find:Pt:^Patient:Ord:CMS Assessment


name: Preadmission Screening and Resident Review (PASRR)


name: Previous assessment reference date for significant correction:Date:Pt:^Patient:Qn:CMS Assessment


name: Assessment reference date - observation end date:Date:Pt:^Patient:Qn:CMS Assessment


name: Medicare-covered stay since the most recent entry:Find:Pt:^Patient:Ord:CMS Assessment


name: Start date of most recent Medicare stay:Date:Pt:^Patient:Qn:CMS Assessment


name: End date of most recent Medicare stay:Date:Pt:^Patient:Qn:CMS Assessment


name: Hearing.ability to hear in last 7D:Find:7D:^Patient:Ord:CMS Assessment


name: Hearing aid used during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Speech clarity.description of speech pattern:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Express ideas and wants in last 7D:Find:7D:^Patient:Ord:CMS Assessment


name: Understanding verbal content:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Vision.ability to see in adequate light in last 7D:Find:7D:^Patient:Ord:CMS Assessment


name: Corrective lenses used:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Brief interview for mental status should be conducted:Find:Pt:^Patient:Ord:CMS Assessment


name: Repetition of three words:Find:Pt:^Patient:Ord:MDSv3


name: Hepatitis C virus core Ag:ACnc:Pt:Ser:Qn:IA


name: Obvious or likely cavity or broken natural teeth in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Inflamed or bleeding gums or loose natural teeth in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Patient lives with on admission for home health:Find:Pt:^Patient:Nom:CARE


name: Patient health questionnaire 2 item:-:Pt:^Patient:-:Reported.PHQ


name: Patient health questionnaire 2 item total score:Score:Pt:^Patient:Qn:Reported.PHQ


name: Temporal Orientation - CARE Acute Care:-:Pt:^Patient:-


name: Other service considered appropriate.other specified:Type:Pt:^Patient:Nom:CARE


name: No services needed after discharge:Find:Pt:^Patient:Nom:CARE


name: Number of unhealed pressure ulcers at each stage - at assessment:-:Pt:^Patient:-


name: Temporal orientation - current day of the week:Find:Pt:^Patient:Ord:BIMS


name: Brief interview for mental status - summary score:Score:Pt:^Patient:Qn:BIMS


name: Should staff assessment for mental status be conducted:Find:Pt:^Patient:Ord:CMS Assessment


name: Short-term memory OK:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Long-term memory OK:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Memory &or recall ability:-:Pt:^Patient:-:MDSv3


name: Can recall current season in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Can recall location of own room in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Can recall staff names and faces in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Can recall that he or she is in a nursing home in last 7D:Find:7D:^Patient:Ord:MDSv3


name: None of the above were recalled in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Cognitive skills for daily decision making:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Acute onset mental status change:Find:Pt:^Patient:Ord:CAM.CMS


name: Should resident mood interview be conducted:Find:Pt:^Patient:Ord:CMS Assessment


name: Resident mood interview (PHQ-9):-:2W:^Patient:-:Reported.PHQ-9.CMS


name: Little interest or pleasure in doing things in last 2W.presence:Find:2W:^Patient:Ord:Reported.PHQ-9.CMS


name: Little interest or pleasure in doing things in last 2W.frequency:Find:2W:^Patient:Ord:Reported.PHQ-9.CMS


name: Feeling down, depressed or hopeless in last 2W.presence:Find:2W:^Patient:Ord:Reported.PHQ-9.CMS


name: Feeling down, depressed or hopeless in last 2W.frequency:Find:2W:^Patient:Ord:Reported.PHQ-9.CMS


name: Trouble falling or staying asleep, or sleeping too much in last 2W.presence:Find:2W:^Patient:Ord:Reported.PHQ-9.CMS


name: Trouble falling or staying asleep, or sleeping too much in last 2W.frequency:Find:2W:^Patient:Ord:Reported.PHQ-9.CMS


name: Feeling tired or having little energy in last 2W.presence:Find:2W:^Patient:Ord:Reported.PHQ-9.CMS


name: Feeling tired or having little energy in last 2W.frequency:Find:2W:^Patient:Ord:Reported.PHQ-9.CMS


name: Poor appetite or overeating in last 2W.presence:Find:2W:^Patient:Ord:Reported.PHQ-9.CMS


name: Poor appetite or overeating in last 2W.frequency:Find:2W:^Patient:Ord:Reported.PHQ-9.CMS


name: Feeling bad about yourself - or that you are a failure or have let yourself or your family down in last 2W.presence:Find:2W:^Patient:Ord:Reported.PHQ-9.CMS


name: Feeling bad about yourself - or that you are a failure or have let yourself or your family down in last 2W.frequency:Find:2W:^Patient:Ord:Reported.PHQ-9.CMS


name: Trouble concentrating on things, such as reading the newspaper or watching television in last 2W.presence:Find:2W:^Patient:Ord:Reported.PHQ-9.CMS


name: Trouble concentrating on things, such as reading the newspaper or watching television in last 2W.frequency:Find:2W:^Patient:Ord:Reported.PHQ-9.CMS


name: Moving or speaking so slowly that other people could have noticed. Or the opposite - being so fidgety or restless that you have been moving around a lot more than usual in last 2W.presence:Find:2W:^Patient:Ord:Reported.PHQ-9.CMS


name: Moving or speaking so slowly that other people could have noticed. Or the opposite - being so fidgety or restless that you have been moving around a lot more than usual in last 2W.frequency:Find:2W:^Patient:Ord:Reported.PHQ-9.CMS


name: Thoughts that you would be better off dead, or of hurting yourself in some way in last 2W.presence:Find:2W:^Patient:Ord:Reported.PHQ-9.CMS


name: Thoughts that you would be better off dead, or of hurting yourself in some way in last 2W.frequency:Find:2W:^Patient:Ord:Reported.PHQ-9.CMS


name: Mood interview total severity score:Score:Pt:^Patient:Qn:Reported.PHQ-9.CMS


name: Responsible staff or provider was informed of potential for resident self harm:Find:Pt:^Patient:Ord:CMS Assessment


name: Staff assessment of resident mood (PHQ-9-OV):-:Pt:^Patient:-:Observed.PHQ-9.CMS


name: Staff assessment of resident mood (PHQ-9-OV)


name: Little interest or pleasure in doing things in last 2W.presence:Find:2W:^Patient:Ord:Observed.PHQ-9.CMS


name: Little interest or pleasure in doing things in last 2W.frequency:Find:2W:^Patient:Ord:Observed.PHQ-9.CMS


name: Antidepressant received in last 7D or since admission &or reentry if less than 7D:Find:7D:^Patient:Ord:MDSv3


name: Hypnotic received in last 7D or since admission &or reentry if less than 7D:Find:7D:^Patient:Ord:MDSv3


name: Anticoagulant received in last 7D or since admission &or reentry if less than 7D:Find:7D:^Patient:Ord:MDSv3


name: Medications received - none of the above were received in last 7D or since admission &or reentry if less than 7D:Find:7D:^Patient:Ord:MDSv3


name: Special treatments and procedures:-:Pt:^Patient:-


name: Special treatments and programs in last 14D:-:Pt:^Patient:-


name: Chemotherapy in last 14D - while not a resident:Find:14D:^Patient:Ord:MDSv3


name: Chemotherapy in last 14D - while a resident:Find:14D:^Patient:Ord:MDSv3


name: Radiation in last 14D - while not a resident:Find:14D:^Patient:Ord:MDSv3


name: Radiation in last 14D - while a resident:Find:14D:^Patient:Ord:MDSv3


name: Oxygen therapy in last 14D - while not a resident:Find:14D:^Patient:Ord:MDSv3


name: Oxygen therapy in last 14D - while a resident:Find:14D:^Patient:Ord:MDSv3


name: Suctioning in last 14D - while not a resident:Find:14D:^Patient:Ord:MDSv3


name: Suctioning in last 14D - while a resident:Find:14D:^Patient:Ord:MDSv3


name: Deprecated Fibrinogen in Platelet poor plasma


name: Deprecated Haptoglobin in Serum or Plasma


name: Deprecated Interferon alpha in Serum or Plasma


name: Number of D to wean patient who is now independent from ventilator:Num:Pt:^Patient:Qn:CARE


name: Indicating that (s)he feels bad about self, is a failure, or has let self or family down in last 2W.presence:Find:2W:^Patient:Ord:Observed.PHQ-9.CMS


name: Indicating that (s)he feels bad about self, is a failure, or has let self or family down in last 2W.frequency:Find:2W:^Patient:Ord:Observed.PHQ-9.CMS


name: Trouble concentrating on things, such as reading the newspaper or watching television in last 2W.presence:Find:2W:^Patient:Ord:Observed.PHQ-9.CMS


name: Trouble concentrating on things, such as reading the newspaper or watching television in last 2W.frequency:Find:2W:^Patient:Ord:Observed.PHQ-9.CMS


name: Moving or speaking so slowly that other people have noticed. Or the opposite - being so fidgety or restless that (s)he has been moving around a lot more than usual in last 2W.presence:Find:2W:^Patient:Ord:Observed.PHQ-9.CMS


name: States that life isn't worth living, wishes for death, or attempts to harm self in last 2W.presence:Find:2W:^Patient:Ord:Observed.PHQ-9.CMS


name: States that life isn't worth living, wishes for death, or attempts to harm self in last 2W.frequency:Find:2W:^Patient:Ord:Observed.PHQ-9.CMS


name: Being short-tempered, easily annoyed in last 2W.presence:Find:2W:^Patient:Ord:Observed.PHQ-9.CMS


name: Being short-tempered, easily annoyed in last 2W.frequency:Find:2W:^Patient:Ord:Observed.PHQ-9.CMS


name: Staff assessment of resident mood total severity score:Score:Pt:^Patient:Qn:Observed.PHQ-9.CMS


name: Hallucinations in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Delusions in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Psychoses - none of the above in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Physical behavioral symptoms directed toward others:NRat:RptPeriod:^Patient:Ord:CMS Assessment


name: Verbal behavioral symptoms directed toward others:NRat:RptPeriod:^Patient:Ord:CMS Assessment


name: Other behavioral symptoms not directed toward others:NRat:RptPeriod:^Patient:Ord:CMS Assessment


name: Overall presence of behavioral symptoms:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Put the resident at significant risk for physical illness or injury:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Significantly interfere with the resident's care:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Significantly interfere with the resident's participation in activities or social interactions:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Put others at significant risk for physical injury:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Significantly intrude on the privacy or activity of others:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Significantly disrupt care or living environment:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Rejection of care - presence and frequency in last 7D:NRat:7D:^Patient:Ord:CMS Assessment


name: Wandering - presence and frequency in last 7D:NRat:7D:^Patient:Ord:CMS Assessment


name: Wandering places resident at significant risk of getting to a potentially dangerous place in last 7D:Find:7D:^Patient:Ord:CMS Assessment


name: Wandering significantly intrudes on the privacy or activities of others in last 7D:Find:7D:^Patient:Ord:CMS Assessment


name: Change in behavioral or other symptoms in last 7D:Find:7D:^Patient:Ord:CMS Assessment


name: How important it is to participate in religious services or practices while in this facility:Find:Pt:^Patient:Ord:CMS Assessment


name: How important it is to participate in religious services or practices while in this facility


name: Primary respondent for daily and activity preferences:Find:Pt:^Patient:Nom:CMS Assessment


name: Staff assessment of daily and activity preferences should be conducted:Find:Pt:^Patient:Ord:CMS Assessment


name: Resident prefers choosing clothes to wear:Find:Pt:^Patient:Ord:MDSv3


name: Resident prefers caring for personal belongings:Find:Pt:^Patient:Ord:MDSv3


name: Resident prefers receiving tub bath:Find:Pt:^Patient:Ord:MDSv3


name: Resident prefers receiving shower:Find:Pt:^Patient:Ord:MDSv3


name: Resident prefers receiving bed bath:Find:Pt:^Patient:Ord:MDSv3


name: Resident prefers receiving sponge bath:Find:Pt:^Patient:Ord:MDSv3


name: Resident prefers snacks between meals:Find:Pt:^Patient:Ord:MDSv3


name: Resident prefers staying up past 8:00 p.m.:Find:Pt:^Patient:Ord:MDSv3


name: Resident prefers family or significant other involvement in care discussions:Find:Pt:^Patient:Ord:MDSv3


name: Resident prefers use of phone in private:Find:Pt:^Patient:Ord:MDSv3


name: Resident prefers place to lock personal belongings:Find:Pt:^Patient:Ord:MDSv3


name: Norovirus genogroup I RNA:PrThr:Pt:Stool:Ord:Probe.amp.tar


name: Norovirus genogroup II RNA:PrThr:Pt:Stool:Ord:Probe.amp.tar


name: Pressure injuries - unstageable due to coverage of wound bed by slough &or eschar:-:Pt:^Patient:-


name: Parainfluenza virus 1:PrThr:Pt:XXX:Ord:Organism specific culture


name: Parainfluenza virus 2:PrThr:Pt:XXX:Ord:Organism specific culture


name: Parainfluenza virus 3:PrThr:Pt:XXX:Ord:Organism specific culture


name: Respiratory syncytial virus:PrThr:Pt:XXX:Ord:Organism specific culture


name: Respiratory pathogens panel:-:Pt:XXX:-:Organism specific culture


name: Surgical operation note disposition:Find:Pt:^Patient:Nar


name: Surgical operation note estimated blood loss:Find:Pt:^Patient:Nar


name: HBA2 gene alpha 3.7kb deletion:Arb:Pt:Bld:Ord:Molgen


name: Methoxsalen 0.02 mg per mL given:Vol:Pt:^Patient:Qn


name: Heparin 10000 U per mL given:Vol:Pt:^Patient:Qn


name: Heparin 5000 U per mL given:Vol:Pt:^Patient:Qn


name: Date of last Clostridium tetani immunization:Date:Pt:^Patient:Qn


name: Time last ate solid food:TmStp:Pt:^Patient:Qn


name: Time last drank liquid:TmStp:Pt:^Patient:Qn


name: Rabies virus immunization status:Hx:Pt:^Patient:Nom


name: Influenza virus immunization status:Hx:Pt:^Patient:Nom


name: Bordetella pertussis immunization status:Hx:Pt:^Patient:Nom


name: Hepatitis A virus immunization status:Hx:Pt:^Patient:Nom


name: Haemophilus influenzae B immunization status:Hx:Pt:^Patient:Nom


name: Human papilloma virus immunization status:Hx:Pt:^Patient:Nom


name: Resident prefers reading books, newspapers, magazines:Find:Pt:^Patient:Ord:MDSv3


name: Resident prefers listening to music:Find:Pt:^Patient:Ord:MDSv3


name: Resident prefers being around animals such as pets:Find:Pt:^Patient:Ord:MDSv3


name: Resident prefers keeping up with the news:Find:Pt:^Patient:Ord:MDSv3


name: Resident prefers doing things with groups of people:Find:Pt:^Patient:Ord:MDSv3


name: Resident prefers participating in favorite activities:Find:Pt:^Patient:Ord:MDSv3


name: Resident prefers spending time away from the nursing home:Find:Pt:^Patient:Ord:MDSv3


name: Resident prefers spending time outdoors:Find:Pt:^Patient:Ord:MDSv3


name: Resident prefers participating in religious activities or practices:Find:Pt:^Patient:Ord:MDSv3


name: Resident prefers none of the above:Find:Pt:^Patient:Ord:MDSv3


name: Transfer in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Dressing upper body in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Deprecated Dressing lower body in last 7D MDSv3


name: Bathing in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Moving from seated to standing position:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Walking (with assistive device if used):Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Turning around and facing the opposite direction while walking:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Moving on and off toilet:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Range of motion:Find:Pt:Upper extremity:Ord:CMS Assessment


name: Range of motion:Find:Pt:Lower extremity:Ord:CMS Assessment


name: Cane &or crutch normally used in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Walker normally used in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Wheelchair (manual or electric) normally used in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Mobility aids - none of the above were normally used in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Ostomy (including suprapubic catheter, ileostomy, and colostomy) present in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Intermittent catheterization used in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Appliances - none of the above used in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Trial of toileting program has been attempted on admission or reentry or since urinary incontinence was noted in this facility:Find:Pt:^Patient:Ord:CMS Assessment


name: Response to toileting program:Find:Pt:^Patient:Ord:CMS Assessment


name: Current toileting program or trial:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Urinary continence in last 7D:Find:7D:^Patient:Ord:CMS Assessment


name: Bowel continence in last 7D:Find:7D:^Patient:Ord:CMS Assessment


name: Bowel toileting program currently being used:Find:Pt:^Patient:Ord:CMS Assessment


name: Cancer in last 30D:Find:30D:^Patient:Ord:MDSv3


name: On scheduled pain medication regimen in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Received PRN pain medications in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Received non-medication intervention for pain in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Pain assessment interview should be conducted:Find:Pt:^Patient:Ord:CMS Assessment


name: Shortness of breath or trouble breathing with exertion in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Shortness of breath or trouble breathing when sitting at rest in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Shortness of breath or trouble breathing when lying flat in last 7D:Find:7D:^Patient:Ord:MDSv3


name: None of the above shortness of breath symptoms in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Life expectancy of less than 6M:Find:Pt:^Patient:Ord:CMS Assessment


name: Problem conditions - none of above:Find:Pt:^Patient:Ord:MDSv3


name: Fall history on admission:-:Pt:^Patient:-:CMS Assessment


name: Fall one or more times in the last Mo prior to admission:Find:1Mo:^Patient:Ord:CMS Assessment


name: Any fracture related to a fall in the 6Mo prior to admission:Find:6Mo:^Patient:Ord:CMS Assessment


name: Has the patient had any falls since admission or prior assessment:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Number of falls since admission or prior assessment:-:RptPeriod:^Patient:-:CMS Assessment


name: Number of falls since admission or prior assessment - no injury:Num:RptPeriod:^Patient:Ord:CMS Assessment


name: Number of falls since admission or prior assessment - injury except major:Num:RptPeriod:^Patient:Ord:CMS Assessment


name: Number of falls since admission or prior assessment - major injury:Num:RptPeriod:^Patient:Ord:CMS Assessment


name: Loss of liquids &or solids from mouth when eating or drinking in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Holding food in mouth &or cheeks or residual food in mouth after meals in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Coughing or choking during meals or when swallowing medications in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Complaints of difficulty or pain with swallowing in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Signs or symptoms of possible swallowing disorder - none of the above:Find:Pt:^Patient:Ord:MDSv3


name: Weight loss of 5% or more in the last Mo or loss of 10% or more in last 6Mo:Find:6Mo:^Patient:Ord:CMS Assessment


name: Parenteral &or IV feeding in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Nasogastric or abdominal feeding tube in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Mechanically altered diet - require change in texture of food or liquids in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Therapeutic diet in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Nutritional approaches in last 7D - none of the above:Find:7D:^Patient:Ord:MDSv3


name: Average fluid intake per day by parenteral or tube feedings in the 7D:VRat:7D:^Patient:Qn:MDSv3


name: Broken or loosely fitting full or partial denture in last 7D:Find:7D:^Patient:Ord:MDSv3


name: No natural teeth or tooth fragments in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Abnormal mouth tissue in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Pressure injury risk by clinical judgment:Find:Pt:^Patient:Ord:MDSv3


name: Pressure injury risk - none of the above:Find:Pt:^Patient:Ord:MDSv3


name: t(9;22)(q34.1;q11)(ABL1,BCR) e19a2 fusion transcript:NCnc:Pt:Bld/Tiss:Qn:Molgen


name: CEH abrine & ricinine panel:MCnc:Pt:Urine:-


name: Number of pressure injuries - unstageable due to coverage of wound bed by slough &or eschar:Num:Pt:^Patient:Qn:CMS Assessment


name: Number of pressure injuries present upon admission &or reentry - unstageable due to coverage of wound bed by slough &or eschar:Num:Pt:^Patient:Qn:CMS Assessment


name: Number of pressure injuries - unstageable with suspected deep tissue injury in evolution:Num:Pt:^Patient:Qn:CMS Assessment


name: Number of pressure injuries present upon admission &or reentry - unstageable with suspected deep tissue injury in evolution:Num:Pt:^Patient:Qn:CMS Assessment


name: Worsening in pressure injury status since last assessment (OBRA, PPS, or Discharge):-:Pt:^Patient:-


name: Number of current pressure injuries not present or were at a lesser stage on prior assessment - stage 2:Num:Pt:^Patient:Qn:CMS Assessment


name: Number of current pressure injuries not present or were at a lesser stage on prior assessment - stage 3:Num:Pt:^Patient:Qn:CMS Assessment


name: Number of current pressure injuries not present or were at a lesser stage on prior assessment - stage 4:Num:Pt:^Patient:Qn:CMS Assessment


name: Healed pressure injuries:-:Pt:^Patient:-:CMS Assessment


name: Pressure injuries were present on the prior assessment:Find:Pt:^Patient:Ord:CMS Assessment


name: Number of pressure injuries noted on prior assessment that have completely closed - stage 2:Num:Pt:^Patient:Qn:CMS Assessment


name: Number of pressure injuries noted on prior assessment that have completely closed - stage 3:Num:Pt:^Patient:Qn:CMS Assessment


name: Number of pressure injuries noted on prior assessment that have completely closed - stage 4:Num:Pt:^Patient:Qn:CMS Assessment


name: Other Ulcers, Wounds and Skin Problems:-:Pt:^Patient:-


name: Diabetic foot pressure injury(ies) in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Surgical wound(s) in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Open lesion(s) other than ulcers, rashes, cuts in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Second or third degree burns in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Other ulcers, wounds, and skin problems - none of above in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Number of venous and arterial ulcers in last 7D:Num:7D:^Patient:Qn:CMS Assessment


name: Skin and pressure injury treatments in last 7D:-:7D:^Patient:-


name: Pressure reducing device for chair provided in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Pressure reducing device for bed provided in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Turning &or repositioning provided in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Nutrition or hydration intervention to manage skin problems provided in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Pressure injury care provided in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Surgical wound care provided in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Applications of ointments &or medications other than to feet provided in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Application of dressings to feet (with or without topical medications) provided in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Skin and pressure injury treatments - none of above provided in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Number of D injectable substances received in last 7D or since admission &or reentry if less than 7D:NRat:7D:^Patient:Qn:CMS Assessment


name: Medications received in last 7D or since admission &or reentry if less than 7D:-:7D:^Patient:-


name: Antipsychotic received in last 7D or since admission &or reentry if less than 7D:Find:7D:^Patient:Ord:MDSv3


name: Antianxiety received in last 7D or since admission &or reentry if less than 7D:Find:7D:^Patient:Ord:MDSv3


name: Tracheostomy care in last 14D - while not a resident:Find:14D:^Patient:Ord:MDSv3


name: Tracheostomy care in last 14D - while a resident:Find:14D:^Patient:Ord:MDSv3


name: Ventilator or respirator in last 14D - while not a resident:Find:14D:^Patient:Ord:MDSv3


name: Ventilator or respirator in last 14D - while a resident:Find:14D:^Patient:Ord:MDSv3


name: BIPAP &or CPAP machine in last 14D - while not a resident:Find:14D:^Patient:Ord:MDSv3


name: BIPAP &or CPAP machine in last 14D - while a resident:Find:14D:^Patient:Ord:MDSv3


name: IV medications in last 14D - while not a resident:Find:14D:^Patient:Ord:MDSv3


name: IV medications in last 14D - while a resident:Find:14D:^Patient:Ord:MDSv3


name: Transfusions in last 14D - while not a resident:Find:14D:^Patient:Ord:MDSv3


name: Transfusions in last 14D - while a resident:Find:14D:^Patient:Ord:MDSv3


name: Dialysis in last 14D - while not a resident:Find:14D:^Patient:Ord:MDSv3


name: Dialysis in last 14D - while a resident:Find:14D:^Patient:Ord:MDSv3


name: Hospice care in last 14D - while not a resident:Find:14D:^Patient:Ord:MDSv3


name: Hospice care in last 14D - while a resident:Find:14D:^Patient:Ord:MDSv3


name: Respite care in last 14D - while not a resident:Find:14D:^Patient:Ord:MDSv3


name: Respite care in last 14D - while a resident:Find:14D:^Patient:Ord:MDSv3


name: Isolation or quarantine for active infectious disease in last 14D - while not a resident:Find:14D:^Patient:Ord:MDSv3


name: Isolation or quarantine for active infectious disease in last 14D - while a resident:Find:14D:^Patient:Ord:MDSv3


name: Influenza virus vaccine received in facility:Find:Pt:^Patient:Ord:CMS Assessment


name: Reason influenza virus vaccine not received:Find:Pt:^Patient:Nom:CMS Assessment


name: Pneumococcal vaccination up to date:Find:Pt:^Patient:Ord:CMS Assessment


name: Therapies in last 7D:-:7 days:^Patient:-


name: Start date of speech language pathology and audiology services:Date:Pt:^Patient:Qn:CMS Assessment


name: End date of speech language pathology and audiology services:Date:Pt:^Patient:Qn:CMS Assessment


name: Start date of occupational therapy:Date:Pt:^Patient:Qn:CMS Assessment


name: End date of occupational therapy:Date:Pt:^Patient:Qn:CMS Assessment


name: Start date of physical therapy:Date:Pt:^Patient:Qn:CMS Assessment


name: End date of physical therapy:Date:Pt:^Patient:Qn:CMS Assessment


name: Start date of respiratory therapy:Date:Pt:^Patient:Qn:MDSv3


name: End date of respiratory therapy:Date:Pt:^Patient:Qn:MDSv3


name: Total minutes of recreational and music therapy in last 7D:Time:7D:^Patient:Qn:CMS Assessment


name: Number of D with at least 15M of recreational and music therapy in last 7D:NRat:7D:^Patient:Qn:CMS Assessment


name: Nursing rehabilitation &or restorative care in last 7D:-:7D:^Patient:-


name: Number of D physician examined the patient in last 14D:NRat:14D:^Patient:Qn:CMS Assessment


name: Number of D physician orders changed in last 14D:NRat:14D:^Patient:Qn:CMS Assessment


name: Physical restraints used in bed - bed rail of any type:Find:Pt:^Patient:Ord:MDSv3


name: Physical restraints used in bed - trunk restraint:Find:Pt:^Patient:Ord:MDSv3


name: Physical restraints used in bed - limb restraint:Find:Pt:^Patient:Ord:MDSv3


name: Physical restraints used in bed - other:Find:Pt:^Patient:Ord:MDSv3


name: Physical restraints used in chair or out of bed - trunk restraint:Find:Pt:^Patient:Ord:MDSv3


name: Physical restraints used in chair or out of bed - limb restraint:Find:Pt:^Patient:Ord:MDSv3


name: Physical restraints used in chair or out of bed - chair prevents rising:Find:Pt:^Patient:Ord:MDSv3


name: Physical restraints used in chair or out of bed - other:Find:Pt:^Patient:Ord:MDSv3


name: Participation in assessment and goal setting:-:Pt:^Patient:-


name: Participation in assessment:Find:Pt:^Patient:Ord:CMS Assessment


name: Resident's overall goals:-:Pt:^Patient:-:CMS Assessment


name: Goals established during assessment process:Find:Pt:^Patient:Nom:CMS Assessment


name: Information source for resident's overall goal:Type:Pt:^Patient:Nom:CMS Assessment


name: Deprecated Therapy supplement for Medicare PPS


name: Medicare part A - HIPPS code for billing:Type:Pt:^Patient:Nom


name: Medicare part A - HIPPS code for billing


name: Medicare part A - RUG version code:Type:Pt:^Patient:Nom


name: State case mix - RUG group:Type:Pt:^Patient:Nom


name: State case mix - RUG version code:Type:Pt:^Patient:Nom


name: Insurance case mix - RUG group:Type:Pt:^Patient:Nom


name: Insurance case mix - RUG version code:Type:Pt:^Patient:Nom


name: Tissue type:Type:Pt:Pressure injury.Largest at most advanced stage:Nom:CMS Assessment


name: Participation in assessment:Find:Pt:^Family or significant other:Ord:CMS Assessment


name: Production or test indicator:Type:Pt:Submission:Nom:MDSv3


name: State assigned facility submission ID:ID:Pt:Facility:Nom


name: Federal employer tax ID:ID:Pt:Software vendor:Nom


name: Other special treatments and programs in last 14D:-:Pt:^Patient:-


name: Respiratory treatments in last 14D:-:Pt:^Patient:-


name: Cancer treatments in last 14D:-:Pt:^Patient:-


name: Deprecated Number of pressure injuries noted on prior assessment that have completely closed


name: Pressure injuries - unstageable with suspected deep tissue injury in evolution:-:Pt:^Patient:-


name: Surgical operation note planned procedure:Find:Pt:^Patient:Nar


name: Surgical operation note planned procedure


name: OTC - Purpose section:-:-:^FDA product label:Nar


name: OTC - Active ingredient section:-:-:^FDA product label:Nar


name: Complement total hemolytic CH50:-:Pt:Ser/Plas:-


name: Current imaging procedure descriptions:Desc:Pt:^Patient:Doc


name: Prior imaging procedure descriptions:Desc:Pt:^Patient:Doc


name: Requested imaging studies information:Find:Pt:^Patient:Doc


name: CEH volatile organic compounds panel:MCnc:Pt:Ser/Plas:-


name: CEH trace metals screen panel:MCnc:Pt:Urine:-


name: CEH nitrogen mustard metabolite panel:MCnc:Pt:Urine:-


name: CEH metabolic toxin panel:MCnc:Pt:Urine:-


name: Surgical operation note implants:Find:Pt:^Patient:Nar


name: Resident believes he or she is capable of increased independence in at least some ADLs:Find:Pt:^Patient:Ord:CMS Assessment


name: Number of pressure injuries - stage 2:Num:Pt:^Patient:Qn:CMS Assessment


name: Number of pressure injuries - stage 3:Num:Pt:^Patient:Qn:CMS Assessment


name: Number of pressure injuries - stage 4:Num:Pt:^Patient:Qn:CMS Assessment


name: Physical restraints used in bed:-:Pt:^Patient:-


name: Physical restraints used in chair or out of bed:-:Pt:^Patient:-


name: Number of D of rehabilitative or restorative techniques:-:Pt:^Patient:-


name: Number of D of rehabilitative or restorative training and skill practice:-:Pt:^Patient:-


name: Influenza virus A hemagglutinin cDNA:Prid:Pt:Isolate:Nom:Probe.amp.tar


name: Influenza virus A neuraminidase RNA:Prid:Pt:Isolate:Nom:Probe.amp.tar


name: BCR-ABL1 kinase domain targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Cortisol^post dose dexamethasone PO overnight:MCnc:Pt:Ser/Plas:Qn


name: SCN5A gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Vaccine Adverse Event Reporting System panel:-:Pt:^Patient:-


name: Vaccine Adverse Event Reporting System panel


name: Cache valley virus RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: California serogroup virus RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Saint Louis encephalitis virus RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Familial long QTS syndrome gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript:NRto:Pt:Bld/Tiss:Qn:Molgen


name: BCR-ABL1 b2a2+b3a2 fusion transcript Molgen Ql (Bld/Tiss)


name: BCR-ABL1 e1a2 fusion protein:PrThr:Pt:Bld/Tiss:Ord:Molgen


name: Anaplasma phagocytophilum Ab.IgG & IgM panel:-:Pt:Ser:Ord


name: Anaplasma phagocytophilum Ab.IgG & IgM panel


name: Aldosterone & renin activity panel:-:Pt:Plas:Qn


name: Amiodarone & Desethylamiodarone panel:MCnc:Pt:Ser/Plas:Qn


name: Ethambutol+rifAMPin:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Flunitrazepam & 7-Aminoflunitrazepam panel:MCnc:Pt:Urine:Qn


name: Minocycline:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Risperidone & 9-Hydroxyrisperidone panel:-:Pt:Ser/Plas:Qn


name: Risperidone & 9-Hydroxyrisperidone panel


name: Tigecycline:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Adenovirus Ab.IgG & IgM panel:-:Pt:Ser:Qn


name: Bordetella pertussis Ab.IgA & IgG panel:-:Pt:Ser:Qn:IA


name: Streptococcus pyogenes enzyme Ab panel:-:Pt:Ser:Ord


name: Hepatitis G virus E2 Ab:PrThr:Pt:Ser:Ord


name: Data Elements for Emergency Department Systems (DEEDS) Release 1.1:-:Pt:^Patient:-


name: Data Elements for Emergency Department Systems (DEEDS) release 1.1


name: Data Elements for Emergency Department Systems (DEEDS) Release 1.0:-:Pt:^Patient:-


name: Data Elements for Emergency Department Systems (DEEDS) Release 1.0


name: Quality Reporting Document Architecture patient list report:Find:Pt:{Setting}^Population:Doc


name: Quality Reporting Document Architecture patient list report


name: Quality Reporting Document Architecture calculated summary report:Find:Pt:{Setting}^Population:Doc


name: Quality Reporting Document Architecture calculated summary report


name: Ciprofloxacin 1.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: DHCR7 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: KIT gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Coagulation surface induced.factor substitution^5M post incubation after addition of normal plasma:Time:Pt:PPP:Qn:Coag


name: Coagulation surface induced.factor substitution^5M post incubation after addition of normal plasma:Time:Pt:PPP^Control:Qn:Coag


name: Genetic analysis discrete result panel:-:Pt:Bld/Tiss:-:Molgen


name: DNA analysis discrete sequence variation panel:-:Pt:Bld/Tiss:-:Molgen


name: DNA analysis discrete sequence variation panel


name: Date and time of most recent arrival in U.S.:TmStp:Pt:^Patient:Qn


name: Shared razor, toothbrushes or nail care items:Find:Pt:^Patient:Nom


name: Occupation related direct blood or body fluid exposure frequency:Find:Pt:^Patient:Nom


name: Number of male sexual partners in 6Mo before symptom onset:NRat:Pt:^Patient:Qn


name: Number of female sexual partners in 6Mo before symptom onset:NRat:Pt:^Patient:Qn


name: Total number of lifetime sexual partners:Num:Pt:^Patient:Qn


name: Physical assault on exposed person involving blood or semen:Find:Pt:^Patient:Nom


name: Stick or puncture with a needle or other object contaminated with blood:Find:Pt:^Patient:Nom


name: Date of actual exposure to blood &or body fluid:Date:Pt:^Patient:Qn


name: Date of actual exposure to blood &or body fluid


name: Microscopic observation:Prid:Pt:Asp:Nom:Rhodamine-auramine fluorochrome stain


name: Mycobacterium tuberculosis A60 Ab.IgM:PrThr:Pt:Ser:Ord:IA


name: Mycobacterium tuberculosis A60 Ab:PrThr:Pt:Ser:Ord:IA


name: Immune stain study:Find:Pt:Tiss:Doc:Immune stain


name: Genetic analysis summary panel:-:Pt:Bld/Tiss:-:Molgen


name: Genetic analysis master panel:-:Pt:Bld/Tiss:-:Molgen


name: Alpha thalassemia gene panel:-:Pt:Bld:-:Molgen


name: Abnormal hemoglobin gene panel:-:Pt:Bld:-:Molgen


name: HBA2 gene alpha 4.2kb deletion:Arb:Pt:Bld:Ord:Molgen


name: HBA2 gene SEA deletion:Arb:Pt:Bld:Ord:Molgen


name: HBA2 gene THAI+FIL+MED+alpha 20.5 deletion:Arb:Pt:Bld:Ord:Molgen


name: Neisseria meningitidis immunization status:Hx:Pt:^Patient:Nom


name: Streptococcus pneumoniae polyvalent immunization status:Hx:Pt:^Patient:Nom


name: Streptococcus pneumoniae conjugated immunization status:Hx:Pt:^Patient:Nom


name: Corynebacterium diphtheriae immunization status:Hx:Pt:^Patient:Nom


name: Polio virus immunization status:Hx:Pt:^Patient:Nom


name: Varicella zoster virus status:Hx:Pt:^Patient:Nom


name: Hepatitis B virus status:Hx:Pt:^Patient:Nom


name: Hepatitis C virus status:Hx:Pt:^Patient:Nom


name: Blood pressure systolic & diastolic:-:Pt:Arterial system:-


name: Protein fractions & Immunoglobulins panel:-:Pt:Ser:-


name: CAV3 gene targeted mutation analysis:PrThr:Pt:Bld/Tiss:Ord:Molgen


name: FIP1L1+PDGFRA rearrangements Molgen Ql (Bld/Tiss)


name: Human papilloma virus 6+11+42+43+44 DNA:PrThr:Pt:Urethra:Ord:Probe.amp.sig


name: Human papilloma virus 6+11+42+43+44 DNA:PrThr:Pt:XXX:Ord:Probe.amp.sig


name: JAK2 gene exon 12 targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: JAK2 gene exon 13 targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: C super little w Ab:Titr:Pt:Ser/Plas:SemiQn


name: F little y super little b Ab:Titr:Pt:Ser/Plas:SemiQn


name: J little k super little a Ab:Titr:Pt:Ser/Plas:SemiQn


name: J little k super little b Ab:Titr:Pt:Ser/Plas:SemiQn


name: J little s super little a Ab:Titr:Pt:Ser/Plas:SemiQn


name: K little p super little a Ab:Titr:Pt:Ser/Plas:SemiQn


name: K little p super little b Ab:Titr:Pt:Ser/Plas:SemiQn


name: L little e super little a Ab:Titr:Pt:Ser/Plas:SemiQn


name: L little e super little b Ab:Titr:Pt:Ser/Plas:SemiQn


name: L little u super little a Ab:Titr:Pt:Ser/Plas:SemiQn


name: L little u super little b Ab:Titr:Pt:Ser/Plas:SemiQn


name: S little d super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: S little d super little a Ab:Titr:Pt:Ser/Plas:SemiQn


name: X little g super little a Ab:Titr:Pt:Ser/Plas:SemiQn


name: S little d super little a Ag:PrThr:Pt:RBC:Ord


name: Platelet aggregation.ristocetin induced^1000 ug/mL:RelACnc:Pt:PRP:Qn


name: Cortisol^20M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Glucose^1.5H post 75 g glucose PO:SCnc:Pt:Ser/Plas:Qn


name: Glucose^45M post 75 g glucose PO:SCnc:Pt:Ser/Plas:Qn


name: Mononuclear cells.immature/100 leukocytes:NFr:Pt:Bld:Qn:Manual count


name: Snowshoe hare virus Ab.IgM:PrThr:Pt:Ser:Ord:IA


name: West Nile virus Ab:Titr:Pt:Ser:SemiQn:HAI


name: Glucose^2.5H post 75 g glucose PO:SCnc:Pt:Ser/Plas:Qn


name: Insulin^5M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin^10M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin^3M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin^15M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin^2M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin^45M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin^4H post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin^5H post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin^6H post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin^4M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin^1M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Phospholipid Ab.IgA & IgG & IgM panel:-:Pt:Ser:Qn


name: Beta 2 glycoprotein 1 Ab.IgA & IgG panel:-:Pt:Ser:Qn


name: Beta 2 glycoprotein 1 Ab.IgA & IgG panel


name: Short myasthenia gravis panel:-:Pt:Ser:Qn


name: Short Fibrin D-dimer FEU & DDU panel:-:Pt:PPP:Qn


name: Date of last eye examination:Date:Pt:^Patient:Qn


name: West Nile virus Ab.IgG & IgM panel:-:Pt:Ser:Qn


name: Heart failure tracking panel:-:Pt:^Patient:-


name: Cardiac ejection fraction method:Type:Pt:Heart.ventricle.left:Nom


name: Oxygen saturation & therapy panel:-:Pt:^Patient:-


name: Short blood pressure panel:-:Pt:^Patient:-


name: Weight & Height tracking panel:-:Pt:^Patient:-


name: Seizure disorder tracking panel:-:Pt:^Patient:-


name: Insulin^20M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Neoplastic cells/100 leukocytes:NFr:Pt:CSF:Qn:Manual count


name: Medical device:-:-:^FDA product label:Nar


name: How are you today: feeling low or worried:Find:Pt:^Patient:Ord


name: How are you today: limited in what I can do:Find:Pt:^Patient:Ord


name: Require help from others:Find:Pt:^Patient:Ord


name: Deprecated Protein C in Platelet poor plasma


name: Influenza virus A swine origin RNA:Prid:Pt:XXX:Nom:Probe.amp.tar


name: Influenza virus A swine origin RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Influenza virus A H1 2009 pandemic RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Influenza virus A H1 2009 pandemic RNA panel:-:Pt:XXX:-:Probe.amp.tar


name: 11-Deoxycortisol^1H post dose corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^30M post dose corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^1H post dose corticotropin:SCnc:Pt:Ser/Plas:Qn


name: Aldosterone^1H post dose corticotropin:SCnc:Pt:Ser/Plas:Qn


name: Cortisol^2.5H post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Cortisol^3H post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Dehydroepiandrosterone^1H post dose corticotropin:SCnc:Pt:Ser/Plas:Qn


name: Estradiol^4H post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Follitropin^4H post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Insulin^7M post dose glucose IV:SCnc:Pt:Ser/Plas:Qn


name: Insulin^5M pre dose glucose:SCnc:Pt:Ser/Plas:Qn


name: Insulin^10M pre dose glucose:SCnc:Pt:Ser/Plas:Qn


name: Insulin^4H post dose glucose IV:SCnc:Pt:Ser/Plas:Qn


name: Insulin^1.5H post dose glucose IV:SCnc:Pt:Ser/Plas:Qn


name: Insulin^10M post dose glucose IV:SCnc:Pt:Ser/Plas:Qn


name: Insulin^1H post dose glucose IV:SCnc:Pt:Ser/Plas:Qn


name: Insulin^1M post dose glucose IV:SCnc:Pt:Ser/Plas:Qn


name: Insulin^2.5H post dose glucose IV:SCnc:Pt:Ser/Plas:Qn


name: Insulin^1H post dose glucagon:SCnc:Pt:Ser/Plas:Qn


name: Insulin^1.5H post dose glucagon:SCnc:Pt:Ser/Plas:Qn


name: Insulin^45M post dose glucagon:SCnc:Pt:Ser/Plas:Qn


name: Insulin^2H post dose glucagon:SCnc:Pt:Ser/Plas:Qn


name: Insulin^30M post dose glucose IV:SCnc:Pt:Ser/Plas:Qn


name: Insulin^3H post dose glucose IV:SCnc:Pt:Ser/Plas:Qn


name: Insulin^5M post dose glucose IV:SCnc:Pt:Ser/Plas:Qn


name: Insulin^45M post dose glucose IV:SCnc:Pt:Ser/Plas:Qn


name: Insulin^2H post dose glucose IV:SCnc:Pt:Ser/Plas:Qn


name: Insulin^3M post dose glucose IV:SCnc:Pt:Ser/Plas:Qn


name: Insulin^7M pre dose glucose:SCnc:Pt:Ser/Plas:Qn


name: Insulin^15M post dose glucose IV:SCnc:Pt:Ser/Plas:Qn


name: Insulin^30M post dose glucagon:SCnc:Pt:Ser/Plas:Qn


name: Lutropin^4H post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Prolactin^20M post dose TRH IV:MCnc:Pt:Ser/Plas:Qn


name: Prolactin^40M post dose TRH IV:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^2H post dose glucagon:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^30M post dose glucose:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^2H post dose glucose:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^1H post dose glucose:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^45M post dose cloNIDine:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^1.5H post dose glucose:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^3H post dose glucagon:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^30M post dose glucagon:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^30M post dose cloNIDine:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^2.5H post dose glucagon:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^1.5H post dose glucagon:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^1H post dose glucagon:MCnc:Pt:Ser/Plas:Qn


name: Testosterone^4H post dose gonadotropin releasing hormone:SCnc:Pt:Ser/Plas:Qn


name: J little s super little b Ab:Titr:Pt:Ser/Plas:SemiQn


name: Leukocytes.disintegrated/100 leukocytes:NFr:Pt:Body fld:Qn:Manual count


name: Microscopic observation:Prid:Pt:Periton fld:Nom:Cyto stain


name: Microscopic observation:Prid:Pt:Pericard fld:Nom:Cyto stain


name: Microscopic observation:Prid:Pt:Plr fld:Nom:Cyto stain


name: Microscopic observation:Prid:Pt:Synv fld:Nom:Cyto stain


name: Follitropin^2nd specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Follitropin^1st specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Follitropin^7th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Ethambutol 2.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Isoniazid 10.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Deprecated Paramomycin [Susceptibility] by Minimum inhibitory concentration (MIC)


name: Pyrazinamide 200.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: rifAMPin 40.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Apolipoprotein A-I & A-II & B & C panel:MCnc:Pt:Ser/Plas:Qn


name: Cerebroside sulfatase & N-Acetylgalactosamine-4-Sulfatase panel:CCnc:Pt:Ser/Plas:Qn


name: Cerebroside sulfatase & N-Acetylgalactosamine-4-Sulfatase panel


name: Borrelia burgdorferi Ab.IgA & IgG & IgM panel:-:Pt:CSF:-


name: Borrelia burgdorferi Ab.IgA & IgG & IgM panel


name: Tissue transglutaminase Ab.IgA & IgG panel:-:Pt:Ser:-


name: Tissue transglutaminase Ab.IgA & IgG panel


name: Yersinia sp Ab.IgG & IgM panel:-:Pt:Ser:-


name: Inject Rh immune globulin:Mass:Pt:Dose:Qn


name: How are you today: pain or discomfort:Find:Pt:^Patient:Ord


name: Frequency of assistance at admission for home health:Find:Pt:^Patient:Ord:CARE


name: Residential Information - Home Health Admission:-:Pt:^Patient:-:CARE


name: Residential Information - Home Health Admission


name: Formula used to compute body surface area


name: 4 hours post dose gonadotropin releasing hormone


name: 5 minutes post incubation after addition of normal plasma


name: at 1.0 s post forced inspiration/Volume.forced inspiration.total


name: post 1.5-2.0 seconds inspiratory hold on ventilator


name: post bronchodilator/Voluntary ventilation.max predicted


name: pre bronchodilator/Voluntary ventilation.max predicted


name: Signs and symptoms of delirium (from CAM)


name: Data Elements for Emergency Department Systems


name: Ultrasound+Estimated from AC+BPD+FL.Hadlock 1985


name: Ultrasound+Estimated from AC+BPD+FL.Woo 1985


name: Ultrasound+Estimated from AC+BPD.Eik-Nes 1982


name: Ultrasound+Estimated from AC+BPD.Hadlock 1984


name: Ultrasound+Estimated from AC+BPD.Thurnau 1983


name: Ultrasound+Estimated from AC+BPD.Weinberger 1984


name: Ultrasound+Estimated from AC+FL+HC.Hadlock 1984


name: Ultrasound+Estimated from AC+FL+HC.Hadlock 1985


name: Ultrasound+Estimated from AD+BPD.Vintzileos 1987


name: Date symptoms of pregnancy first noted:Date:Pt:^Patient:Qn


name: Deprecated Fluid output.wound drain: VRat: 10H: Surgical site: Qn:


name: Deprecated Fluid output.wound drain: VRat: 1H: Surgical site: Qn:


name: Deprecated Fluid output.wound drain: VRat: 24H: Surgical site: Qn:


name: Deprecated Fluid output.wound drain: VRat: 8H: Surgical site: Qn:


name: Deprecated Fluid output.wound drain: VRat: 12H: Surgical site: Qn:


name: Deprecated Thigh Bilateral MRI Multisection


name: Deprecated Monoacetylmorphine [Mass/volume] in Urine


name: Deprecated Fetal Cerebral artery anterior Resistivity index Doppler.calculated


name: Deprecated Resistivity index of Cerebral artery middle Doppler.calculated


name: Flavocoxid/Zinc, Chelated 250 MG-50 MG Oral Capsule


name: Flavocoxid/Zinc, Chelated 500 MG-50 MG Oral Capsule


name: CATHETER,URETHRAL COUDE 20FR BARD #010120


name: INCONT BRIEF ENTRUST PLUS,XTRA ABSORBENT LARGE


name: TRACH STOMA PROTECTOR,FOAM 2IN X 2.125IN


name: Camphor/Menthol/Petrolatum/Phenol 1%-0.6%-41%-0.5% Topical application Stick


name: Stick, Multi Ingredient Topical application Stick


name: LaMICtal ODT Patient Titration Kit (Green)


name: LaMICtal ODT Patient Titration Kit (Orange)


name: LaMICtal XR Patient Titration Kit (Green)


name: LaMICtal XR Patient Titration Kit (Orange)


name: {1 (113400 MG) (ammonium lactate 120 MG/ML Topical Foam [Pro 12]) / 1 (45000 MG) (mometasone furoate 1 MG/ML Topical Cream [Momexin]) } Pack [Momexin Kit]


name: blood pressure test kit-adult extra large cuff


name: blood pressure test kit-adult medium cuff


name: blood pressure test kit-adult small cuff


name: pen needle, diabetic, safety 29 gauge X 3/16" MISCELL NEEDLE, DISPOSABLE


name: microfibrillar collagen 35 mm X 35 mm TOPICAL SHEET (EA)


name: microfibrillar collagen 70 mm X 35 mm TOPICAL SHEET (EA)


name: microfibrillar collagen 70 mm X 70 mm TOPICAL SHEET (EA)


name: Paradigm Silhouette Infusion 13MM Full Set-18 inch


name: Paradigm Silhouette Infusion 17MM Full Set-32 inch


name: cholesterol and blood glucose meter MISCELL EACH


name: nutritional tx. glucose intolerance,lactose-free,soy/fiber 0.06 gram-1.2 kcal/mL ORAL LIQUID (ML)


name: nutritional therapy for impaired digestive function 8.2 gram-472 kcal/100 gram ORAL POWDER (GRAM)


name: {7 (ethinyl estradiol 0.025 MG / norgestimate 0.18 MG Oral Tablet) / 7 (ethinyl estradiol 0.025 MG / norgestimate 0.215 MG Oral Tablet) / 7 (ethinyl estradiol 0.025 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Tri-Lo-Sprintec 28 Day]


name: emollient combination no.44 TOPICAL FOAM (GRAM)


name: hemodialysis solution no.71 without potassium


name: {1 (70000 MG) (salicylic acid 60 MG/ML Topical Foam) / 1 (70000 MG) (urea 400 MG/ML Topical Foam) } Pack


name: Arterial oxygen saturation (observable entity)


name: Time of patient arrival to location for anesthesia


name: Monitoring of cardiac output using pulse contour analysis


name: Measurement of triple marker in late gestation serum specimen


name: Measurement of total hemoglobin concentration using dipstick


name: Palmar 45 degree medial-dorsolateral projection


name: Measurement of heavy metal in urine specimen


name: Microscopy for organism in urine specimen


name: Right dorsal-left ventral oblique projection


name: Plantar 75 degree proximal-dorsodistal oblique projection


name: Extirpation of lesion of meninges of clivus of skull


name: Husband spermatozoa donor for artificial insemination


name: Measurement of acetone in serum specimen


name: Percutaneous transluminal insertion of stent into axillary vein using fluoroscopic guidance with contrast


name: Percutaneous thrombolysis of internal jugular vein using fluoroscopic guidance


name: Excision of lesion of intradural intramedullary spinal cord


name: Ventral right-dorsal left oblique projection


name: Ventral 30 degree left-dorsal right oblique projection


name: Measurement of aluminum in 24 hour urine specimen


name: Left 20 degree ventral-right dorsal oblique projection


name: Measurement of tobramycin peak concentration


name: Grafting of bone using cancellous chip allograft


name: Primary reverse polarity total prosthetic replacement of shoulder joint using cement


name: Repair of multiple tears of rotator cuff of shoulder


name: Right rostral-left caudal oblique projection


name: Active compression decompression cardiopulmonary resuscitation with use of inspiratory impedance threshold device


name: Measurement of barbiturate in serum specimen


name: Anterior and posterior attachment of correctional instrument to spine


name: Closure of ventricular septal defect using fluoroscopic guidance


name: Measurement of 5 aminolevulinic acid in 24 hour urine specimen


name: Repair of capsule and anterior labrum for stabilization of glenohumeral joint


name: Education about folic acid in first trimester


name: Aspirate sent to laboratory for examination


name: Quantitative measurement of cystine in random urine specimen


name: Left 20 degree dorsal-right ventral oblique projection


name: Determination of information related to transfusion


name: Percutaneous transluminal insertion of stent into subclavian vein using fluoroscopic guidance with contrast


name: Right ventral-left dorsal oblique projection


name: Right 30 degree caudal-left rostral oblique projection


name: Right 20 degree rostral-left caudal oblique projection


name: Fine needle aspiration biopsy of sublingual gland


name: Right 45 degree ventral-left dorsal oblique projection


name: Dorsal 60 degree medial-plantarolateral oblique projection


name: Dorsal 40 degree lateral-plantaromedial oblique projection


name: Measurement of pH in vaginal fluid specimen using nitrazine yellow for detection of rupture of amniotic membrane


name: Revision of decompression of median nerve at wrist


name: Transposition of ligament for stabilization of joint


name: Measurement of occult blood in stool specimen using immunoassay


name: Percutaneous transluminal occlusion of interposition tube prosthesis between pulmonary artery and subclavian artery


name: Arthroscopic excision of infrapatellar fat pad


name: Rostral 20 degree dorsal-caudoventral oblique projection


name: Number of hours oxygen therapy required per day


name: Start time for preparation of patient in procedure room


name: Delayed hypersensitivity skin test for histoplasmin done


name: Measurement of free and total carnitine in urine specimen


name: Measurement of total bilirubin in cord blood specimen


name: Measurement of amikacin trough concentration


name: Measurement of vancomycin peak concentration


name: Quantitative measurement of ketone in serum specimen


name: Measurement of occult blood in body fluid specimen


name: Percutaneous transluminal chemoembolization of artery


name: Radionuclide study of whole body for detection of right to left shunt using macroaggregated albumin


name: Measurement of fasting glucose in urine specimen using dipstick


name: Measurement of gentamicin peak concentration


name: Ventral 20 degree rostral-dorsocaudal oblique projection


name: Fluoroscopy guided percutaneous transluminal angioplasty of axillary vein with contrast


name: Measurement of amfetamine in meconium specimen using gas chromatography mass spectrometry


name: Quantitative measurement of polychlorinated biphenyl in blood specimen using gas chromatography


name: Left 30 degree caudal-right rostral oblique projection


name: Revisional posterior fusion of atlantoaxial joint using transarticular screw


name: Measurement of rifampin in serum specimen using high performance liquid chromatography


name: Time of establishment of adequate anesthesia


name: Primary reconstruction of lamina of cervical spine


name: Measurement of beta 2 microglobulin in cerebrospinal fluid specimen


name: Implantation of cardioverter defibrillator with three electrode leads


name: Repair of obstetric laceration of perineum and anal sphincter and mucosa of rectum


name: Left 45 degree ventral-right dorsal oblique projection


name: Time ready for discharge from post anesthesia care unit


name: Fluoroscopy guided percutaneous transluminal angioplasty of inferior vena cava with contrast


name: Referral for ambulatory electrocardiogram


name: Measurement of occult blood in gastric fluid specimen


name: Percutaneous radiofrequency ablation of lesion of bone


name: Revision of reverse polarity total prosthetic replacement of shoulder joint using cement


name: Measurement of corrected end-tidal carbon monoxide


name: Calculation of ionized calcium concentration


name: Screening for sickle cell disease (procedure)


name: Fine needle aspiration biopsy of abdominal cavity structure


name: Monitoring of intraocular pressure during vitrectomy


name: Percutaneous transluminal angioplasty of internal jugular vein using fluoroscopic guidance with contrast


name: Disease activity score in rheumatoid arthritis using C-reactive protein (observable entity)


name: Bath ankylosing spondylitis functional index score


name: Urinalysis with reflex to microscopy and culture


name: Measurement of aldosterone in body fluid specimen


name: Posterior fusion of atlantoaxial joint using pedicle screw


name: Measurement of nuclear matrix protein 22 in urine specimen


name: Dorsal 40 degree medial-palmarolateral oblique projection


name: Unrelated known spermatozoa donor for artificial insemination


name: Measurement of vancomycin trough concentration


name: Measurement of glycine in cerebrospinal fluid specimen


name: Measurement of carcinoembryonic antigen in body fluid specimen


name: Measurement of ethanol using gas chromatography


name: Dorsal 35 degree lateral-palmaromedial oblique projection


name: Duration of early morning joint stiffness


name: Bath ankylosing spondylitis metrology index score


name: Primary hybrid prosthetic replacement of knee joint using cement


name: Quantitative measurement of amino acid in cerebrospinal fluid specimen


name: Related spermatozoa donor for artificial insemination


name: Dorsal 60 degree medial-palmarolateral oblique projection


name: Jugular bulb oxygen saturation (observable entity)


name: Remanipulation of fracture of short bone and fixation using screw


name: Lateral 45 degree dorsal 50 degree proximal-medioplantarodistal oblique projection


name: Percutaneous transhepatic transplantation of pancreatic islet cell using fluoroscopic guidance


name: Disease activity score using 28 joint count


name: Measurement of immunoglobulin A in serum specimen


name: Measurement of creatinine clearance in peritoneal dialysis fluid specimen


name: Attention to cemented hybrid prosthetic replacement of knee joint


name: Placement of brain surface electrode for electroencephalography


name: Fluoroscopy guided percutaneous transluminal insertion of stent into femoral vein with contrast


name: Measurement of ammonia in arterial blood specimen


name: Revisional posterior lumbar medial facetectomy


name: Revisional fusion of occipitocervical junction


name: Dorsal 45 degree lateral-palmaromedial oblique projection


name: Capillary oxygen saturation (observable entity)


name: Measurement of amprenavir peak concentration


name: Unknown spermatozoa donor for artificial insemination


name: Measurement of sulfonylurea in urine specimen by screening method


name: Measurement of amphetamine in serum specimen


name: Measurement of amikacin peak concentration


name: Measurement of cadmium in serum specimen


name: Revision of one component of total prosthetic replacement of elbow joint using cement


name: Repair of capsule and anterior and posterior labrum for stabilization of glenohumeral joint


name: Treatment planning for repetitive transcranial magnetic stimulation


name: Monitoring of cardiac output using continuous esophageal Doppler


name: Division of fascia of finger for Dupuytren contracture


name: Transarterial chemoembolization of hepatic artery


name: Time of patient arrival in post anesthesia care location


name: Assessment for risk of cardiovascular disease


name: Insertion of hybrid prosthetic replacement of knee joint using cement


name: Measurement of amylase in timed urine specimen


name: Fluoroscopy guided percutaneous transluminal insertion of stent into internal jugular vein with contrast


name: Placement of depth electrode into brain for electroencephalography


name: Measurement of tobramycin trough concentration


name: Fluoroscopy guided percutaneous transluminal cutting balloon angioplasty of internal jugular vein with contrast


name: Revisional laminoplasty of cervical spine


name: Primary reverse polarity total prosthetic replacement of shoulder joint not using cement


name: Laparoscopy assisted vaginal hysterectomy with bilateral salpingo-oophorectomy


name: Radiographic imaging of lymphatic system using contrast


name: Measurement of fractionated porphyrins in plasma specimen


name: Measurement of efavirenz peak concentration


name: Estimation of creatinine clearance by Cockcroft-Gault formula


name: Intermittent pneumatic compression stockings


name: Fine needle aspiration biopsy of parotid gland


name: Dorsal 60 degree lateral-plantaromedial oblique projection


name: Dorsal 35 degree medial-plantarolateral oblique projection


name: International Consultation on Incontinence questionnaire


name: Forced vital capacity before bronchodilation


name: Measurement of albumin in pleural fluid specimen


name: Measurement of barbiturate in urine specimen using fluorescent polarization immunoassay


name: Quantitative measurement of acylcarnitine in blood specimen


name: Percutaneous transluminal ablation of septum of heart using chemical substance


name: Revisional hemilaminectomy for decompression of lumbar spine


name: Right 20 degree ventral-left dorsal oblique projection


name: Primary hemilaminectomy for decompression of lumbar spine


name: Posterior fusion of atlantoaxial joint using transarticular screw


name: Dorsal 65 degree proximal-plantarodistal oblique projection


name: Measurement of heavy metal in blood specimen


name: Measurement of heavy metal in tissue specimen


name: Qualitative measurement of cystine in random urine specimen


name: Microscopic examination for dysmorphic red blood cells in urine specimen


name: Measurement of chloride in stool specimen


name: Dorsal 35 degree lateral-plantaromedial oblique projection


name: Right 45 degree dorsal-left ventral oblique projection


name: Measurement of occult blood in single stool specimen


name: Single photon emission computed tomography of ventilation of lung


name: Examination of learning disabled patient


name: Endoscopy and biopsy of lesion of ureter using rigid ureteroscope


name: Primary posterior lumbar medial facetectomy


name: Measurement of alpha fetoprotein as marker for malignant neoplasm


name: Dorsal 60 degree lateral-palmaromedial oblique projection


name: Right 20 degree dorsal-left ventral oblique projection


name: Construction of external stoma of urinary system


name: Repair of capsule and posterior labrum for stabilization of glenohumeral joint


name: Left 45 degree dorsal-right ventral oblique projection


name: Left ventral-right dorsal oblique projection


name: Measurement of alcohol in blood specimen


name: Tape for stabilization of intravenous catheter, device


name: Measurement of bicarbonate in venous blood specimen


name: Percutaneous thrombolysis of axillary vein using fluoroscopic guidance with contrast


name: Anastomosis of pulmonary artery to subclavian artery


name: Measurement of ratio of apolipoprotein A to apolipoprotein B


name: Lateral 45 degree dorsal 50 degree proximal-mediopalmarodistal oblique projection


name: Left 20 degree rostral-right caudal oblique projection


name: Measurement of total hemoglobin concentration


name: Inferomedial to superolateral oblique view


name: Measurement of mercaptopurine metabolite


name: Highest recorded European pressure ulcer advisory panel classification


name: Time of patient arrival in healthcare facility


name: Measurement of ciclosporin 2 hours after dosing


name: Guaiac test for occult blood in feces specimen


name: Measurement of occult blood in three separate stool specimens


name: Superior vena cava oxygen saturation (observable entity)


name: Measurement of glucose 1 hour after glucose challenge for glucose tolerance test


name: Evaluation of airway equipment condition


name: Time of arrival of anesthesia care provider to anesthetizing location


name: European pressure ulcer advisory panel classification


name: Percutaneous replacement of pulmonary valve using fluoroscopic guidance


name: Measurement of creatinine clearance normalized to body surface area in peritoneal dialysis fluid specimen


name: Quantitative measurement of mercaptopurine


name: Left caudal-right rostral oblique projection


name: Occlusion of patent ductus arteriosus using embolization coil


name: Endo-esophageal ultrasonography of mediastinum


name: Completion time of procedure room cleaning


name: Dorsal 35 degree medial-palmarolateral oblique projection


name: Time of patient departure from procedure room


name: Reconstruction of extra-articular ligament for stabilization of joint


name: Arthroscopic matrix-induced autologous chondrocyte implantation of joint


name: Quantitative measurement of acylcarnitine in plasma specimen


name: Fine needle aspiration biopsy of adipose tissue


name: Left rostral-right caudal oblique projection


name: Specimen obtained by bronchial aspiration


name: Measurement of chloride in peritoneal fluid specimen


name: Implantation of artificial sphincter in anorectum


name: Single photon emission computed tomography of perfusion of lung


name: Incision of vein using ultrasound guidance


name: Excision of lesion of breast using wire guidance


name: Measurement of glucose 4 hours after glucose challenge for glucose tolerance test


name: Fatty acid profile to detect peroxisomal defect


name: Stereoscopic view incremented from baseline


name: Arthrolysis after total prosthetic replacement of knee joint


name: Arthroscopic harvest of autologous chondrocytes


name: Measurement of chloride in 24 hour stool specimen


name: Quantitative measurement of cannabinoids


name: Measurement of alprazolam in serum specimen


name: Number of alcohol units consumed on heaviest drinking day


name: Measurement of tramadol in urine specimen


name: Quantitative measurement of tricyclic antidepressant in serum specimen


name: Closure of atrial septal defect using septal occluder device


name: Division of mitral valve chordae tendineae


name: Measurement of calcium in dialysis fluid specimen


name: Conversion to hybrid prosthetic replacement of knee joint using cement


name: Implantation of radioactive substance into prostate


name: Grafting of bone marrow using allograft from unmatched unrelated donor


name: Dorsal 40 degree medial-plantarolateral oblique projection


name: Revisional repair of multiple tears of rotator cuff of shoulder


name: Revisional posterior fusion of atlantoaxial joint using pedicle screw